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Abstract 
 
 Using a palladium-catalyzed reductive N-heteroannulation methodology previously 
discovered in our labs, a 20 mmol synthetic route to methyl indole-4-carboxylate has been 
developed.  Methyl indole-4-carboxylate is synthesized in four steps, with the key step being the 
reductive cyclization of methyl 2-ethenyl-3-nitrobenzoate in good overall yield.  This cyclization 
method has been modified and applied to the preparation of quinoxalines, 2-quinoxalinones and 
other heterocyclic compounds.  We also propose a possible mechanism for these transformations. 
 In addition, a novel method to 2-alkylbenzimidazoles has been developed.  The thermal 
reactions of 2-azidonitrobenzenes with various aldehydes give 2-alkylbenzimidazoles generally 
in moderate yield. 
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Part I 
 
Synthesis of Methyl Indole-4-carboxylate by Reductive N-Heteroannulation of 
Methyl 2-Ethenyl-3-nitrobenzoate 
 
 
1.  Introduction 
 The indole ring system can be found in many physiologically active compounds both 
naturally occurring and non-naturally occurring.  Two of the more well known biologically 
active indoles are strychnine, a potent toxin, and sumatriptan, an antimigraine medicine marketed 
by GlaxoSmithKline under the name Imitrex (Figure 1).  Other indole-containing compounds 
exhibit biological properties including antibacterial,1 antiallergy2 and antitumor3 activity.  The 
development of synthetic routes to indoles is therefore a worthwhile goal of researchers. 
 
Figure 1.  Strychnine and Sumatriptan (Imitrex) 
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 One of the more commonly known routes is the Fischer indole synthesis (Scheme 1).4  
This method involves the reaction of an arylhydrazine (1) and a ketone (2) to form an 
arylhydrazone (3) which is then treated with a Lewis acid such as ZnCl2 to form the indole (4).  
A potential drawback of the Fischer method is if the substrate contains an unsymmetrically 
 1
substituted aryl ring, the reaction could lead to regioisomers.  The potential for regioisomers also 
exists if some unsymmetrical ketones are used. 
 
Scheme 1.  Fischer Indole Synthesis 
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 Another named route to indoles is the Madelung synthesis (Scheme 2).5  In this method, 
2-tolylacetamide (5) is treated with base to form the benzyl carbanion, which then reacts with the 
carbonyl and, upon elimination, forms the indole (6).  A strong base, such as an alkyllithium, is 
usually required for this reaction making it unsuitable for molecules with certain functional 
groups. 
 
Scheme 2.  Madelung Indole Synthesis 
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 The Bischler method of indole preparation6 involves the reaction of aminobenzenes (7) 
with α-haloketones (8) to form α-(N-arylamino)ketones (9) which are then cyclized in the 
 2
presence of an acid catalyst to form the corresponding indoles (10) (Scheme 3).  Just as with the 
Fischer method, regiochemistry becomes a problem with substrates containing unsymmetrically 
substituted aryl rings. 
 
Scheme 3.  Bischler Indole Synthesis 
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1.1.  Palladium-Catalyzed Indole Syntheses 
 Recently, a new method for the preparation of indoles was developed in our group.7  This 
procedure, detailed in Scheme 4, involved the reductive N-heteroannulation of 2-nitrostyrenes 
(11) in the presence of a palladium catalyst, a phosphine and carbon monoxide to give indoles 
(12) in good yields.  With no strong acid or base required in this reaction and no regiochemical 
issues, this method is potentially more useful than many others. 
 
Scheme 4.  Palladium-catalyzed Cyclization of 2-Nitrostyrenes 
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 3
 Other palladium-catalyzed routes to indoles include the reaction of 2-allylaminobenzenes 
(13) with PdCl2(CH3CN)2 as the catalyst and benzoquinone as the reoxidant to give indoles (14) 
generally in good yields (Scheme 5).8
 
Scheme 5.  Palladium-catalyzed Cyclization of 2-Allylaminobenzenes 
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 In addition to the reactions of alkenes, some methods have been developed that involve 
the cyclization of arylalkynes.  One such method uses PdCl2(CH3CN)2 as a catalyst to convert 2-
alkynylanilides (15) to N-acylated indoles9 (16) as described in Scheme 6. 
 
Scheme 6.  Palladium-catalyzed Cyclization of 2-Alkynylanilides 
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 Most of the indole-forming reactions of the type described in Scheme 4 were performed 
on a relatively small scale (1-2 mmol) in a glass pressure tube (20-40 mL).  We wanted to know 
if it was feasible to produce indoles on a larger scale (20-50 mmol) using our method and so a 
 4
scaled-up procedure was developed.  That procedure was used to synthesize methyl indole-4-
carboxylate and it is presented. 
 
2.  Results and Discussion 
 The synthesis of methyl indole-4-carboxylate is detailed in Scheme 7.  Methyl 2-methyl-
3-nitrobenzoate (17) was previously synthesized in our laboratory according to a literature 
procedure.10  Compound 18 was prepared easily from 17 via radical bromination.  The bromide 
was transformed into triphenylphosphonium bromide 19 by reaction with triphenylphosphine.  
Treatment with triethylamine formed the ylide necessary for the subsequent Wittig reaction with 
formaldehyde to form 20 in 71% from bromide 18.  Because of the increased scale of the 
reaction and to avoid the explosion of a smaller glass pressure vessel (the pressure we used was 
approaching the upper limit of the manufacturer rating), it was necessary to use a large stainless 
steel high pressure Parr reactor for the conversion of 20 to 21.  The reaction of 20 (4.10 g, 20.00 
mmol) in the presence of Pd(OAc)2 (269 mg, 1.2 mmol), triphenylphosphine (1.30 g, 4.8 mmol) 
and CO (6 atm) at 90 °C in acetonitrile (100 mL) for 27 h gave methyl indole-4-carboxylate (21) 
(3.06 g, 17.5 mmol) in 87% yield. 
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Scheme 7.  Synthesis of Methyl Indole-4-carboxylate (21) 
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3.  Conclusions 
 We have developed a mild and efficient multi-mmol synthesis of methyl indole-4-
carboxylate.  The key step of this synthetic route is the reductive N-heteroannulation of methyl 2-
ethenyl-3-nitrobenzoate using a protocol previously developed in our laboratory. 
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Part II 
 
Synthesis of Quinoxalines and 2-Quinoxalinones by Palladium-Catalyzed N-
Heteroannulation Reactions 
 
 
1.  Introduction 
 The quinoxaline structure is a moiety found in many compounds exhibiting biological 
activity.  Examples of biologically active quinoxalines are riboflavine, also known as vitamin B2, 
an important nutritional factor, and oxythioquinox, an antifungal agent (Figure 2).  Other 
quinoxalines exhibit antifungal,11 antituberculosis,12 antiepilepsy,13 antibacterial14 and 
antitumor15 activities.  This wide range of physiological activity makes the quinoxaline ring 
system an attractive synthetic target. 
 
Figure 2.  Riboflavine and Oxythioquinox 
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 Most previous syntheses of quinoxalines involve the Hinsberg condensation of 
substituted 1,2-diaminobenzenes with 1,2-dicarbonyl compounds.  This method generally 
resulted in the formation of isomeric products from unsymmetrical starting materials.  Katoh et 
 7
al reported the synthesis of quinoxalines 24 and 25 by the reaction of methyl 3,4-
diaminobenzoate (22) and ethyl pyruvate (23) (Scheme 8).16  The products were obtained in 87% 
as a 1:1 mixture of regioisomers. 
 
Scheme 8.  The Work of Katoh et al 
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 It is possible, however, to achieve some degree of selectivity in the production of 
regioisomers if the nucleophilicity of the amino groups or the electrophilicity of the carbonyls is 
sufficiently different.  Ammar et al described the formation of quinoxalines 28 and 29 as a 2:1 
mixture from 4-benzoyl-1,2-diaminobenzene (26) and pyruvic acid (27) (Scheme 9).17  In this 
case the benzoyl moiety deactivates the para-amino group leaving the meta-amino group to react 
with the more reactive ketone to form 28 as the major isomer. 
 
Scheme 9.  The Work of Ammar et al 
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 It is also possible to utilize substituent effects and reaction conditions simultaneously to 
achieve selectivity.  The work of Paglietti et al is detailed in Scheme 10.  In this example, 
substituted 1,2-diaminobenzenes (30) are reacted with phenyl glyoxal (31) to form quinoxalines 
32 and 33 in different ratios if the reaction was performed in neutral, acidic or basic conditions.18
 
Scheme 10.  The Work of Paglietti et al 
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 The Hinsberg-type condensation reactions of 1,2-diaminobenzenes with 1,2-
dielectrophiles are not limited to 1,2-dicarbonyl compounds.  Kano et al reported the synthesis of 
quinoxalines 32 and 33 in 27-30% yield from the condensation of substituted 1,2-
diaminobenzenes (30) and phenacyldimethylsulfonium iodide (34) (Scheme 11).19  Selectivity 
was achieved by using the appropriate substituents on the aryl ring.  When the substituent was 
electron withdrawing, the para-amino group was deactivated and the meta-amino group reacted 
with the preferred α-methylene carbon of the sulfonium salt to form only 32.  Conversely, when 
 9
the substituent was electron donating, the para-amino group reacted at this preferred site to form 
only 33. 
 
Scheme 11.  The Work of Kano et al 
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 McKillop et al reported the formation of aminoquinoxalines 36 and 37 from the reaction 
of substituted 1,2-diaminobenzenes (30) and ethyl carboethoxyformimidate (35) (Scheme 12).20  
As in the previous examples, selectivity can be achieved in this reaction depending on the 
electronic nature of the substituent. 
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Scheme 12.  The Work of McKillop et al 
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 Other variations of the 1,2-dielectrophiles are acetylenedicarboxylates.  Iwanami 
described the reaction of 1,2-diaminobenzene (38) with diethyl acetylenedicarboxylate (39) to 
form 40 in almost quantitative yield (Scheme 13).21  In this reaction, one amine reacts with an 
ester and the other amine is in position to react in a Michael-fashion.  The yield of this reaction is 
good; however, the use of unsymmetrical starting materials would lead to the formation of 
regioisomers. 
 
Scheme 13.  The Work of Iwanami 
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 11
 Makino et al reported the reaction of 41 with diketene (42) to give N-oxide 43 in 70% 
yield.  Subsequent reduction of 43 with sodium hydrogensulfite gives quinoxalinone 44 in 75% 
yield (Scheme 14).22 
 
Scheme 14.  The Work of Makino et al 
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 Krchňák et al reported the synthesis of 46 on solid support via the reduction of 45 to the 
aryl amine and subsequent intramolecular reaction with the ester (Scheme 15).23  After cleavage 
of the solid support, 46 could be easily oxidized to the corresponding fully aromatic quinoxaline. 
 
Scheme 15.  The Work of Krchňák et al 
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 Quinoxalines of type 49 have been synthesized in good to moderate yields by the reaction 
of 1-(2-isocyanophenyl)pyrrole (47) with Eschenmoser’s salts (48), as reported by Kobayashi et 
al (Scheme 16).24 
 
Scheme 16.  The Work of Kobayashi et al 
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 Kundu et al described the synthesis of 2-aroylquinoxalines (51) by the copper iodide-
catalyzed cyclization of alkyne 50 (Scheme 17).25  The products are formed in moderate yields 
with the lowest yields reported when the aryl group on the alkyne contains an electron donating 
substituent in the para position (ex.  Ar = p-CH3O-C6H4).  This is presumably because the 
alkyne is more electron rich and, therefore, is a less favorable position for the amine to attack. 
 
Scheme 17.  The Work of Kundu et al 
 
                                
N
NHTs
Ts Ar
N
N
Ar
O
50 51 (40-60%)
CuI, K2CO3
DMF, 100oC
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 There are many synthetic routes to the quinoxaline ring system; however, many of these 
methods have limitations.  In most cases, regiochemistry is an issue unless one of only a few 
functional groups is used.  Often another limitation is low yields.  We have developed a synthetic 
method to quinoxalines and 2-quinoxalinones via N-heteroannulation of N-(2-
nitroaryl)enamines.  Regioselectivity is not an issue in our method and a variety of functional 
groups are compatible with the reaction conditions.  Also, our reactions typically proceeded 
smoothly in high conversion.  The novel synthesis of an array of quinoxalines and 2-
quinoxalinones is presented. 
 
2.  Results and Discussion 
 Our initial goal was to utilize the aforementioned palladium-catalyzed cyclization 
conditions (Scheme 4) to prepare a series of benzimidazoles from a variety of imines (Scheme 
18).  Compound 54 was prepared in moderate yield from the condensation of 2-
nitroaminobenzene (52) and 4-nitrobenzaldehyde (53).  The subsequent cyclization, however, 
failed.  Even after numerous attempts to refine the cyclization conditions by employing Pd(dba)2 
(dba = dibenzylideneacetone), 1,3-bis(diphenylphosphino)propane (dppp) and N,N-
dimethylformamide (DMF), the reactions were still met with no success. 
 
Scheme 18.  Synthesis of 54 and Cyclization Attempt 
 
NH2
NO2 OHC
NO2
52 53
Ph-H
4A mol.sieves+
NO2
N
NO2
54 (54%)
Pd(OAc)2, PPh3
CO (4 atm), 70oC
CH3CN
NR
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 Next, we tried to prepare an aryl imine with an aliphatic substituent.  However, the 
reaction of 2-nitroaminobenzene (52) and 2-methylpropanal (55) produced enamine 56 instead of 
the expected imine.  Since the mechanism for the cyclization reaction is not well established, we 
decided to react 56 under CO atmosphere and in the presence of Pd(dba)2 and dppp in the hopes 
of getting the corresponding 2-isopropylbenzimidazole.  Instead, this reaction afforded 
quinoxaline 57 and quinoxalinone 58 in 71% and 11%, respectively (Scheme 19). 
 
Scheme 19.  Novel Synthesis of Quinoxalines and 2-Quinoxalinones 
 
                      
NH2
NO2
52
+ H
CH3
CH3
O
55 56 (73%)
57 (71%)
Ph-H
4A mol. sieves
NO2
N
H
CH3
CH3
Pd(dba)2, dppp
CO (4 atm), 70oC
CH3CN
58 (11%)
N
N
N
N
CH3
CH3
CH3
CH3
O
H
HH
+
 
 
 With this result in hand, we set out to determine the scope and limitations of this novel 
cyclization reaction.  First, we needed to synthesize a variety of enamines as precursors to 
cyclization.  Most of the enamines were prepared by the condensation of a commercially 
available substituted 2-nitroaminobenzene and an α,α-disubstituted aldehyde, most commonly 2-
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methylpropanal.  Most of the reactions were carried out at ambient temperature under inert 
atmosphere in the presence of 4 Å molecular sieves with benzene or CH2Cl2 as the solvent. 
 Table 1 shows the results of the condensation reactions.  Some modifications of the 
reaction conditions were made for the synthesis of compounds 56, 68 and 70.  Initially, for 
compound 56, the reaction mixture was cooled to -20 °C to avoid hydrolysis of the product.  This 
reaction produced 56 in 73% yield, but it was later determined that the cooling was unnecessary 
and it was abandoned on future reactions.  The yields of compounds 68 and 70 were improved by 
heating the reaction mixture in a standard microwave oven.  Compound 82 was isolated in 85% 
yield as an inseparable mixture of cis and trans isomers. 
 Generally, the condensation reactions produced the desired enamines in very good yields.  
The lower yield of 68 may be attributed to the increased steric bulk around the amino group.  
Also, slightly lower yields were obtained when the substituent on the aryl ring was an electron 
withdrawing group.  This served to deactivate the amine and render it a much poorer 
nucleophile.  By the same token, the nucleophilicity of the amine was increased when the 
substituent was an electron donating group, producing generally higher yields of enamines.  It 
also seems that enamines from a 2-nitroaminobenzene and a straight-chain aliphatic aldehyde 
cannot be formed by this method.  Starting material was recovered unchanged from the reaction 
of 52 and 83 (Table 1, Entry 14). 
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Table 1.  Synthesis of Enamines by Condensation Reactions 
 
Entry Aniline Aldehyde Enamine
1
2
3
4
5
NH2
NO2
H
CH3
CH3
O
5552 56 (73%)a
NO2
N
H
CH3
CH3
NH2
NO2
59 60 (89%)
NO2
N
H
CH3
CH3
H3C H3C
NH2
NO2
61
H3CO
62 (95%)
NO2
N
H
CH3
CH3
H3CO
NH2
NO2
63
Cl
64 (100%)
NO2
N
H
CH3
CH3
Cl
NH2
NO2
65
Cl
66 (88%)
NO2
N
H
CH3
CH3
Cl
55
55
55
55
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Table 1 (continued) 
 
Entry Aniline Aldehyde Enamine
6
7
8
9
10
NH2
NO2
H
CH3
CH3
O
5567 68 (5%)b
NO2
N
H
CH3
CH3CH3 CH3
NH2
NO2
69
O2N
70 (78%)b
NO2
N
H
CH3
CH3
O2N
NH2
NO2
71
CH3
72 (36%)
NO2
N
H
CH3
CH3
CH3
NH2
NO2
73
Ph
O
74 (20%)
NO2
N
H
CH3
CH3
Ph
O
NH2
NO2
75
H3CO
O
76 (74%)
NO2
N
H
CH3
CH3
H3CO
O
55
55
55
55
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Table 1 (continued) 
 
Entry Aniline Aldehyde Enamine
11
12
13
14
NH2
NO2
7761 78 (88%)
NO2
N
H
H3CO
H
O
H3CO
H
Ph
Ph
O
79 80 (91%)
NO2
N
H
Ph
Ph
H3CO
NH2
NO2
63
Cl
H
Ph
O
81 82 (85%)c
NO2
N
H
Ph
Cl
a) Reaction temperature was -20oC.  b) Reactions were heated in a microwave oven.  c) Product was 
isolated as a 1:1 mixture of cis and trans isomers.
NH2
NO2
52 83 not observed
NO2
N
H
C5H11
H
O
61
 
 
 Since compounds 71 and 75 are not commercially available, it was necessary to prepare 
them for the condensation reactions.  Compound 71 was prepared via Curtius rearrangement of 
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3-methyl-2-nitrobenzoic acid (84) (Scheme 20).  Compound 75 was prepared by the acid-
promoted esterification of 4-amino-3-nitrobenzoic acid (85) (Scheme 21). 
 
Scheme 20.  Curtius Rearrangement of 3-Methyl-2-nitrobenzoic Acid 
 
                                    
NO2
CH3
OH
O
1) SOCl2
2) NaN3
3) AcOH/H2O, reflux
NH2
NO2
CH3
84 71 (60%)  
 
Scheme 21.  Esterification of 4-Amino-3-nitrobenzoic Acid 
 
                         
NO2
85
HO
O
CH3OH, Ph-H
H2SO4, reflux NO2
75 (69%)
H3CO
O
NH2 NH2
 
 
 As well as pursuing substrates with a substituted aryl ring, we also synthesized an aryl 
enamine containing the pyridine moiety.  Scheme 22 shows the condensation of 2-amino-3-
nitropyridine (86) and 2-methylpropanal (55).  This reaction gave the desired compound 87, but 
in low yield.  Another product of the reaction was compound 88, which resulted from the attack 
of a second amine on the imine intermediate. 
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Scheme 22.  Synthesis of 87 and 88 
 
N
NO2
NH2
H
CH3
CH3
O
55 87 (20%)
N
NO2
N
H
CH3
CH3
86
+
CH2Cl2
4A mol. sieves + N
N N
N
CH3H3C
NO2 NO2HH
88 (44%)  
 
 In order to expand the scope of the methodology, we decided to synthesize enamines 
containing an α,β-unsaturated carbonyl moiety.  Scheme 23 details the preparation of two of 
these compounds.  Compound 90 was prepared in 32% yield by the condensation of 2-
nitroaminobenzene (52) and 1,2-cyclohexandione (89).  Compound 92 was prepared in the same 
way in 70% yield by the reaction of 2-nitroaminobenzene (52) and 1,3-cyclohexandione (91). 
 
Scheme 23.  Synthesis of 90 and 92 
 
                         
NO2
NH2
52
+
O
O H2SO4, Ph-H
reflux
89
NO2
N
90 (32%)
H O
NO2
NH2
52
+
O
H2SO4, Ph-H
reflux
91
NO2
N
92 (70%)
H
O
O
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 The synthesis of compounds 95, 96 and 97 is described in Scheme 24.  The enamines 
were prepared via an addition-elimination reaction of the corresponding 2-nitroaminobenzene 
and (E)-4-methoxy-3-buten-2-one (94), which was prepared according to Neuenschwander’s 
procedure.26  It is interesting to note that only the cis isomer in each case is formed.  According 
to Fedor et al, the cis isomer is the thermodynamically more stable isomer when the possibility 
for hydrogen bonding exists between the carbonyl and amino groups.27  These reactions 
proceeded smoothly and afforded the desired products in high yields. 
 
Scheme 24.  Addition Elimination Reactions 
 
NH2
NO2
+
R1
R2
H3CO CH3
O
94
p-TsOH, CH2Cl2
reflux
N
NO2
R1
R2
H
O CH3
95 (98%), R1=R2=H
96 (86%), R1=H, R2=CH3
97 (71%), R1=CH3, R2=H
52 R1=R2=H
59 R1=H, R2=CH3
93 R1=CH3, R2=H
 
 
 With the preparation of several enamines, we now could test the scope of the cyclization 
reaction.  The first attempted cyclization of enamine 56 using Pd(dba)2 (6 mol%), dppp (6 mol%) 
and carbon monoxide (4 atm) in acetonitrile at 70 °C gave quinoxaline 57 and quinoxalinone 58 
in 71% and 11%, respectively (Scheme 19).  Despite the success of this reaction, attempts to 
cyclize other enamines under the same conditions failed.  With further refining of the reaction 
conditions, we found that the following worked the best:  Pd(dba)2 (6 mol%), dppp (6 mol%), 
1,10-phenanthroline monohydrate (phen) (12 mol%), CO (6 atm) in DMF at 70 °C. 
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 We tested these reaction conditions on the substrates shown in Table 1.  The results of 
these cyclizations are summarized in Table 2.  Most of the reactions proceeded smoothly to give 
a mixture of quinoxalines and 2-quinoxalinones in high total yields.  The cyclization of 62 gave 
compounds 100 and 101 in 76% and 11%, respectively.  It is interesting to note that this reaction 
was performed again under seemingly identical conditions and the yields of 100 and 101 were 
57% and 40%, respectively.  This result has since been irreproducible.  Lower yields were 
typically seen in the cases that had an electron withdrawing group on the aryl ring; no evidence 
of either expected product was seen in the attempted cyclization of 70.  The cyclization of 74 
produced a product that was tentatively assigned as 110 (Table 2, Entry 9).  Numerous attempts 
to purify compound 110 by column chromatography failed and the assignment was based on the 
interpretation of the 1H NMR and 13C NMR spectra.  The cyclization of 76 gave an inseparable 
mixture of 111 and 112 (Table 2, Entry 10).  The yields of these two compounds were calculated 
from the 1H NMR spectrum.  It is interesting to note that the cyclization of compound 80 
produced only the quinoxaline and none of the quinoxalinone was seen (Table 2, Entry 12).  The 
cyclization of 82 gave slightly different products than the other reactions in that both 116 and 
117 are fully aromatic (Table 2, Entry 13). 
 The differences in the NMR spectra of quinoxalines and 2-quinoxalinones are quite clear.  
For example, in the 1H NMR spectra, the gem-dimethyl signal for the quinoxalinone is generally 
more downfield than that of the quinoxaline.  For 3,4-dihydro-3,3,6-trimethyl-2-quinoxalinone 
(99), this signal appears at 1.40 ppm, while for 1,2-dihydro-2,2,7-trimethylquinoxaline (98), this 
signal is at 1.30 ppm.  The C-H on the nitrogen-containing ring of 98 shows an NMR signal at 
7.23 ppm, while 99 shows no such signal.  In the 13C NMR, the aliphatic quaternary carbon of 
compound 99 appears at 55.4 ppm, while the analogous carbon in 98 appears at 50.3 ppm. 
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Table 2.a  Synthesis of Quinoxalines and 2-Quinoxalinones 
 
Entry Enamine Quinoxaline Quinoxalinone
1
2
3
4
5
56
NO2
N
H
CH3
CH3
60
NO2
N
H
CH3
CH3
H3C
62
NO2
N
H
CH3
CH3
H3CO
64
NO2
N
H
CH3
CH3
Cl
66
NO2
N
H
CH3
CH3
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
57 (71%)b 58 (11%)b
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
98 (50%) 99 (45%)
H3C H3C
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
100 (76%) 101 (11%)
H3CO H3CO
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
102 (56%) 103 (16%)
Cl Cl
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
104 (29%) 105 (45%)
Cl Cl Cl
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Table 2 (continued) 
 
Entry Enamine Quinoxaline Quinoxalinone
6
7
8
9
10
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
106 (27%) 107 (42%)
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
not observed not observed
O2N O2N
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
108 (63%) 109 (12%)
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
110 (<52%) not observed
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
111 (3%)c 112 (2%)c
68
NO2
N
H
CH3
CH3CH3
70
NO2
N
H
CH3
CH3
O2N
72
NO2
N
H
CH3
CH3
CH3
74
NO2
N
H
CH3
CH3
Ph
O
76
NO2
N
H
CH3
CH3
H3CO
O
CH3 CH3
CH3 CH3
Ph
O
Ph
O
H3CO
O
H3CO
O
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Table 2 (continued) 
 
Entry Enamine Quinoxaline Quinoxalinone
11
12
13
14
N
N
N
N
H
O
HH
113 (70%) 114 (13%)
N
N
N
N
H
O
HH
Ph
Ph
Ph
Ph
115 (69%) not observed
H3CO H3CO
N
N
N
N OH
116 (25%) 117 (14%)
N N
N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
118 (34%) 119 (6%)
78
NO2
N
H
H3CO
80
NO2
N
H
Ph
Ph
H3CO
82
NO2
N
H
Ph
Cl
87
N
NO2
N
H
CH3
CH3
H3CO H3CO
Cl ClPh Ph
a) General conditions: Pd(dba)2 (6 mol%), dppp (6 mol%), phen (12 mol%), CO (6 atm), DMF, 70oC.  
For more exact details, see: Experimental Section.  b) Conditions: Pd(dba)2 (6 mol%), dppp (6 mol%), 
CO (4 atm), CH3CN, 70oC.  c) Products were isolated as an inseparable mixture.  Yields were 
estimated from the 1H NMR spectrum.  
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 Next, we examined the cyclization of enamines derived from the condensation of 2-
nitroaminobenzenes and ketones.  Compound 90 formed a mixture of three products when 
subjected to the reaction conditions (Scheme 25).  Naturally occurring 1-hydroxyphenazine (120) 
is formed from the reaction in low yield.  Compounds 121 and 122 were also formed in low 
yields.  Compound 122 was aromatized using Pd/C (12.5 mol% Pd), 1,2,4-trimethylbenzene (10 
eq) in diphenyl ether at 230 °C for 20 h to give 120 in 20% yield.  This leads us to believe that 
the product of the cyclization reaction is 122.  In the reaction mixture, compound 122 is 
dehydrogenated by catalytic Pd(0) to give 120.  Compound 90 may also undergo reduction of the 
nitro group to an amine and subsequent reaction of the amine with the carbonyl.  Ultimately, this 
compound will tautomerize to form 121. 
 
Scheme 25.  Cyclization of 90 and Aromatization of 122 
 
N
H
NO2
O
Pd(dba)2, dppp, phen
CO (6 atm), 70oC, DMF
N
N
OH
N
N
N
N
+ +
O
90 120 (6%) 121 (8%) 122 (15%)
Pd/C, 1,2,4-trimethylbenzene
PhOPh, 230oC122 120 (20%)  
 
 The reaction of 92 under slightly modified cyclization conditions gave 120 in relatively 
low yield (Scheme 26).  The only modification to the conditions in this case was the increased 
temperature (120 °C).  Although it could be envisioned that 122 could be formed in this reaction, 
it was not observed. 
 27
Scheme 26.  Cyclization of 92 
 
                
N
H
NO2
Pd(dba)2, dppp, phen
CO (6 atm),120oC, DMF
N
N
OH
92 120 (26%)
O
 
 
Acetylquinoxalines have also been prepared in low yields using our cyclization conditions.  The 
reactions generally lead to the formation of the products in low yield.  However, it is our hope 
that with small modifications to the procedure, our method will be a viable synthetic route to 
acetylquinoxalines.  The reaction of 95 under the cyclization conditions gave 122 in 6% yield.  
Something interesting was discovered when the aryl ring was functionalized.  When 96 was 
subjected to the same conditions, a mixture of regioisomers 124 and 125 were obtained in 13% 
yield.  Similarly, when 97 was cyclized, a mixture of the same isomers was obtained in 4% yield.  
When the results of the reactions are compared, the ratios of products are not the same indicating 
that the mixture formed in each case is not the thermodynamic mixture, but the kinetic mixture.  
The results of these reactions are shown in Scheme 27. 
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Scheme 27.  Synthesis of Acetylquinoxalines 
 
95
NO2
N
H
CH3O
N
N
CH3
O
123 (6%)
Pd(dba)2, dppp, phen
CO (6 atm), 90oC, DMF
96
NO2
N
H
CH3O
N
N
CH3
O
124
Pd(dba)2, dppp, phen
CO (6 atm), 70oC, DMF
N
N
CH3
O
125
H3C
H3C
+
isolated as a mixture (1:1.3) in 13% yield
97
NO2
N
H
CH3O
N
N
CH3
O
124
Pd(dba)2, dppp, phen
CO (6 atm), 70oC, DMF
N
N
CH3
O
125
H3C
H3C
+
isolated as a mixture (3.7:1) in 4% yield
H3C
H3C
 
 
 We propose that the cyclization reactions proceed via the formation of a palladium-bound 
nitrene intermediate.  The formation of this intermediate will be discussed in Part III.  We also 
propose that the regioisomeric products formed in the above examples arise from the migration 
of the four carbon unit from one nitrogen to the other, resulting in the formation of isomeric 
nitrenes 126 and 130 (Scheme 28).  These nitrenes should react in the same manner as discussed 
later in Part III to form the appropriate quinoxalines 125 and 124.  It is assumed in each case that 
the major product arises from the initially formed nitrene and not the nitrene formed from the 
migration. 
 29
Scheme 28.  Formation of Isomeric Nitrenes 
 
96
NO2
N
H
CH3O
97
NO2
N
H
CH3O
H3C
H3C
126
N
N
H
CH3O
H3C
127
N
N
CH3HO
H3C
H3C N
N CH3
HO
128
130
N
N
H
CH3O
H3C
129
N
N
CH3HO
H3C
 
 
 As previously discussed, our attempts to form enamines by the condensation of 2-
nitroaminobenzenes and straight-chain aliphatic aldehydes failed.  This result led us to try a 
different route.  It is known that azides react with triphenylphosphine via the Staudinger reaction 
to form iminophosphoranes.28  These iminophosphoranes can then undergo aza-Wittig reactions 
with aldehydes and ketones to form imines.  We decided to react 2-nitrophenylazides with 
triphenylphosphine, and then an aldehyde, in the hopes of isolating the corresponding imine or 
enamine.  The reaction of 2-azidonitrobenzene (131), triphenylphoshine and heptanal (83) in the 
manner described above gave a red mixture which is a typical characteristic of the formation of 
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an enamine.  An attempt to purify the enamine by column chromatography resulted in complete 
decomposition of the product.  It was then decided to form the expected enamine and subject the 
crude product to the cyclization conditions without further purification.  Scheme 29 describes 
this two-step sequence that produced 2-pentylquinoxaline (132), 2-pentylquinoxaline-1-oxide 
(133) and 2-hexylbenzimidazole (134) in 25%, 8% and 14%, respectively.  These results indicate 
that the aza-Wittig reaction first forms an imine, which would be expected to undergo nitrene 
insertion to produce benzimidazole 134.  The imine might also isomerize to the enamine, which 
upon reaction with the nitrene would give quinoxaline 132.  The mass spectrum of the compound 
designated to be 133 shows a peak at m/z = 199.  This peak would correspond to [M-17]+, or the 
loss of OH, since the molecular weight of the N-oxide is 216.  According to Bartoszek et al,29 
quinoxaline-N-oxides substituted at the ortho position to the NO group give characteristic [M-
OH]+ fragments.  This, along with the rest of the fragmentation pattern and spectral data, led us 
to the conclusion that we did, in fact, isolate compound 133. 
 
Scheme 29.  Synthesis of 132, 133 and 134 
 
N3
NO2
1) Ph3P, Et2O
2) heptanal, CHCl3, reflux
3) Pd(dba)2, dppp, phen
    CO (6 atm), 70oC, DMF N
N
C5H11 N
N
C5H11
O
+ +
N
N
H
C6H13
131 132 (25%) 133 (8%) 134 (14%)  
 
 The reaction to form enamine 68 proceeded, although in very low yield (Table 1, Entry 
6).  It was our idea that a reaction of 2-azido-3-nitrotoluene (135) and 2-methylpropanal (55) in 
the manner described above might give a higher two-step yield of the cyclization products.  In 
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fact, the reaction gave 67, 106 and 136 in 8%, 11% and 62%, respectively, and is described in 
Scheme 30. 
 
Scheme 30.  Synthesis of 67, 106 and 136 
 
N3
NO2
1) Ph3P, Et2O
2) 2-methylpropanal, CHCl3, reflux
3) Pd(dba)2, dppp, phen
    CO (6 atm), 70oC, DMF
135
CH3
NH2
NO2
CH3
+ +
N
N
H
CH3
CH3
CH3
106 (11%)67 (8%) 136 (62%)
N
N
H
CH3
CH3
CH3
 
 
 For the above study, it was necessary to synthesize two aryl azides for the 
Staudinger/aza-Wittig sequences.  Compounds 131 and 135 were prepared in good yields via 
diazotization of the corresponding aminobenzene followed by treatment with sodium azide.  The 
results of these reactions are shown in Scheme 31. 
 
Scheme 31.  Preparation of Azides 131 and 135 
 
                              
NH2
NO2
N3
NO2
1) HCl, NaNO2, 0oC
2) NaN3
R R
131 (80%), R = H
135 (75%), R = CH3
52 R = H
67 R = CH3  
 
 In most of the cyclization reactions two products – a quinoxaline and a 2-quinoxalinone – 
are formed in appreciable yields.  We wanted to test various changes in the reaction conditions to 
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see if one product could be formed exclusively.  First, we subjected enamine 62 to the 
cyclization conditions and varied only the CO pressure.  The reaction conditions for this set of 
experiments was Pd(dba)2 (6 mol%), dppp (6 mol%), phen (12 mol%), CO (various pressures), 
DMF, 70 °C, 18 h (Scheme 32).  The results of this study are summarized in Table 3.  The 
results show that carbon monoxide is crucial for the reaction to take place.  In the absence of 
carbon monoxide, the reaction did not proceed (Table 3, Entry 1).  It is also interesting to note 
that the reaction proceeded well under ambient carbon monoxide pressure, indicating that for 
some substrates, higher pressures may not be necessary.  It also seems that overall yields 
increase as the pressure is increased. 
 
Scheme 32.  Cyclization Reactions under Various CO Pressures 
 
Pd(dba)2, dppp, phen
CO, 70oC, DMF, 18 h
62
NO2
N
H
CH3
CH3
H3CO N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
100 101
H3CO H3CO
+
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Table 3.a  Results of Cyclization Reactions under Various CO Pressures 
 
                    
Entry CO pressure (atm) 100 101
0b
ambientc
2
4
6
8
16
0%
70%
60%
86%
76%
88%
99%
0%
10%
9%
6%
11%
3%
1%
1
2
3
4
5
6
7
a) Isolated yields of 100 and 101 are reported.
b) No carbon monoxide was added to the reaction vessel.
c) The reaction vessel was flushed with carbon monoxide.  
 
 Next, we varied the reaction times for the cyclizations.  The reaction conditions for this 
set of experiments was Pd(dba)2 (6 mol%), dppp (6 mol%), phen (12 mol%), CO (6 atm), DMF, 
70 °C (Scheme 33).  The results of this study are summarized in Table 4.  It was determined that 
longer reaction times served no benefit and any differences in the yields of products were 
probably within standard error. 
 
Scheme 33.  Cyclization Reactions with Various Reaction Times 
 
Pd(dba)2, dppp, phen
CO (6 atm), 70oC, DMF
62
NO2
N
H
CH3
CH3
H3CO N
N
N
N
H
O
HH
CH3
CH3
CH3
CH3
100 101
H3CO H3CO
+
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Table 4.  Results of Cyclization Reactions with Various Reaction Times 
 
                    
Entry reaction time (h) 100 101
1
4
18
36
73%
77%
76%
88%
10%
2%
11%
1%
1
2
3
4
 
 
 We also tested the effect of H2O in the reaction mixture.  The reaction conditions for this 
set of experiments was Pd(dba)2 (6 mol%), dppp (6 mol%), phen (12 mol%), CO (6 atm), 70 °C, 
18 h (Scheme 34).  The results of this study are summarized in Table 5.  When the reaction was 
performed using H2O as the solvent no reaction took place (Table 5, Entry 1).  This result may be 
because of a limited solubility of the enamine and other reagents in H2O.  When the reaction was 
performed in a 1:1 mixture of DMF/H2O an increased yield of quinoxaline 100 was seen, while 
no 101 was isolated (Table 5, Entry 2).  The most interesting result was obtained when the 
reaction was performed in DMF, but 6 equivalents of H2O were added to the reaction mixture 
(Table 5, Entry 3).  In this experiment 100 was isolated in 80% yield, while 101 was not seen. 
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Scheme 34.  Cyclization Reactions with Various Solvent Mixtures 
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Table 5.  Results of Cyclization Reactions with Various Solvent Mixtures 
 
                    
Entry Solventa 100 101
H2O
DMF/H2O (1:1)
DMFb
0%
37%
80%
0%
0%
0%
1
2
3
a) General conditions: Pd(dba)2 (6 mol%), dppp (6 mol%), phen (12 mol%), 
CO (6 atm), 70oC, 18 h.  The solvent used is listed.  b) 6 equivalents of H2O 
was added to the reaction mixture.  
 
 Encouraged by the previous results, we decided to attempt the cyclization of more 
substrates under the conditions described in Table 5, Entry 3.  The results of these reactions are 
shown in Scheme 35.  When enamine 64 was subjected to these new conditions, quinoxaline 102 
was obtained in 96% yield, while quinoxalinone 103 was obtained in 4% yield.  The 
quinoxaline/quinoxalinone yield was 56%/16% when the reaction was performed without the 
addition of H2O (Table 2, Entry 4).  Similarly, when 66 was reacted under the conditions that 
included the addition of 6 eq of H2O, 104 and 105 were obtained in 81% and 18%, respectively.  
This result is especially interesting given that the same reaction performed under the original 
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conditions gave quinoxalinone 105 as the major product (Table 2, Entry 5).  Further investigation 
is planned to determine the scope of these reaction conditions. 
 
Scheme 35.  Cyclization Reactions with the Addition of Excess Water 
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3.  Conclusions 
 A mild and efficient route to quinoxalines and 2-quinoxalinones using a palladium-
catalyzed cyclization reaction was developed.  A variety of functional groups and substitution 
patterns are tolerated by this reaction.  However, generally lower yields are obtained for 
substrates containing an electron withdrawing group.  Also, it appears as if the ratio of products 
obtained in the reaction can be manipulated by slightly changing the reaction conditions, namely 
the addition of H2O to the reaction mixture. 
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Part III 
 
Investigation into the Mechanism of the Palladium-Catalyzed N-
Heteroannulation Reactions 
 
 
1.  Mechanistic Investigation 
 The mechanism of the cyclizations of N-(2-nitroaryl)enamines to quinoxalines and 2-
quinoxalinones has been investigated.  Transition metal-catalyzed deoxygenation of organic nitro 
compounds has been proposed to proceed via the formation of nitrene, or nitrenoid, 
intermediates.30  Carbon monoxide is crucial for the reaction to proceed, functioning as a 
reducing agent to give a metal-bound nitrene and carbon dioxide.  Metal-bound nitrenes have 
been previously reported.  For example, a ruthenium-bound derived from 2-nitrosobiphenyl has 
been isolated and characterized by X-ray crystallography.31  Decomposition of this complex gave 
the expected nitrene insertion product.  We propose a mechanism for the formation of a 
palladium-bound nitrene intermediate under our reaction conditions.  This mechanism is detailed 
in Scheme 36. 
 
Scheme 36.  Proposed Mechanism for the Formation of a Palladium-bound Nitrene 
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 The mechanism for the formation of the quinoxaline/quinoxalinone products is unclear; 
however, we propose possible mechanisms for their respective formations.  The proposed 
mechanism for the formation of quinoxalines is detailed in Scheme 37.  In this mechanism, the 
partially negative carbon of the enamine reacts with the partially positive nitrogen of the 
palladium-bound nitrene in a formal [2 + 2] intramolecular cycloaddition to form bicyclic 
species 144.  Sequential β-hydride elimination to give 145 followed by reductive elimination 
would form the quinoxaline (57) and regenerate the palladium(0) catalyst.   
 
Scheme 37.  Proposed Mechanism for the Formation of Quinoxalines 
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 Our proposed mechanism for the formation of 2-quinoxalinones is detailed in Scheme 38.  
Before complete deoxygenation to give the palladium-bound nitrene, insertion of the alkene into 
the intermediately formed metallacycle 146 (a palladium-bound nitrosoarene) occurs.  Two 
different insertion products can be envisioned; one resulting from the insertion of the alkene into 
the Pd-O bond (147) and the other from the insertion into the N-O bond (148) of the 
metallacycle.  The latter seems to be the species more likely formed since a simple β-hydride 
elimination-reductive elimination sequence would give a 2-quinoxalinone.  Intramolecular 
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insertions of alkenes into metal-bound nitrosoarenes, the first step in this sequence, have been 
proposed.32
Scheme 38.  Proposed Mechanism for the Formation of 2-Quinoxalinones 
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 By subjecting compound 102 to the cyclization conditions we have shown that oxidation 
of the quinoxaline does not lead to the 2-quinoxalinone; compound 102 was recovered 
unchanged from the reaction mixture.  By an analogous reaction of 105, we have also shown that 
the 2-quinoxalinone is not reduced under the same conditions.  These studies are illustrated in 
Scheme 39. 
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Scheme 39.  Reaction of 102 and 105 under Cyclization Conditions 
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 It is established that a nitrene species is formed upon the thermolysis of azides.30  
Therefore, in order to further investigate the mechanism of the cyclization reactions, we 
attempted to prepare N-(2-azidoaryl)enamines.  The attempted condensation of 2-
azidoaminobenzenes with aldehydes in the presence of molecular sieves under previously 
described conditions was met with no success.  However, the condensation of 2-
azidoaminobenzene and various aryl aldehydes in the presence of catalytic acetic acid in 
refluxing ethanol to form the corresponding imine is described by Alajarín et al.33  Although the 
product isolated by Alajarín was an imine, we thought that by using aliphatic aldehydes and 
considering our previous experience with the condensations of aminobenzenes and, for example, 
2-methylpropanal, that it might be possible to form the enamine under these conditions. 
 The condensation of 2-azido-4-chloroaminobenzene (150) (the synthesis of 150 will be 
discussed in the next section) and 2-methylpropanal (55) was attempted.  The only isolated 
product was 5-chloro-2-isopropylbenzimidazole (151) in 61% yield.  This result indicates that if 
 41
a nitrene is formed upon heating, it reacts with the initially formed imine from the condensation 
reaction to give the benzimidazole.  The benzimidazole is the expected nitrene insertion product 
from such a reaction according to Krbechek et al.34  The result of this reaction is described in 
Scheme 40.  The formation of 2-alkylbenzimidazoles under these conditions was pursued further 
and the results are described in the next section. 
 
Scheme 40.  Synthesis of Benzimidazole 151 
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 We still desired to isolate a N-(2-azidoaryl)enamine, but it was clear that the 
condensation of an aminobenzene and an aldehyde was not the route to take.  We attempted the 
addition-elimination reaction of 2-azido-4-methylaminobenzene (152) (the synthesis of 152 will 
be discussed in the next section) and (E)-4-methoxy-3-buten-2-one (94) to form (Z)-4-(2-azido-
4-methylphenylamino)-3-buten-2-one (153).  This reaction proceeded smoothly to give the 
desired product in 78% yield (Scheme 41). 
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Scheme 41.  Preparation of 153 
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 With this result in hand, compound 153 was refluxed in ethanol in the presence of 
catalytic p-toluenesulfonic acid.  This reaction produced an inseparable mixture (6:1) of 
quinoxalines 125 and 124 (Scheme 42) similar to the cyclizations of N-(2-nitroaryl)enamines 96 
and 97 (Scheme 27, Part II).  This indicates that a nitrene intermediate is a possibility in the 
palladium-catalyzed N-heteroannulations of N-(2-nitroaryl)enamines to form quinoxalines and 2-
quinoxalinones. 
 
Scheme 42.  Synthesis of 124 and 125 
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 It has been reported that organic azides react with a variety of transition metals, such as 
Mo,35 W36 and Fe,37 to form metal-bound nitrenes.  We decided to react compound 153 with a 
Pd(0) catalyst in the hopes of forming the palladium-bound nitrene species.  The reaction of 
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compound 153 with Pd(dba)2 and dppp in DMF at ambient temperature produced a product that 
is tentatively designated as 154 in 18% yield (Scheme 43).  This result also supports the 
hypothesis that a nitrene intermediate is involved in the formation of the quinoxaline ring system 
by the palladium-catalyzed N-heteroannulations of N-(2-nitroaryl)enamines. 
 
Scheme 43.  Synthesis of 154 
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 In our proposed mechanism for the formation of a nitrene intermediate (Scheme 36), it 
can be envisioned that species 140, which is formally palladium coordinated to a nitroso group, 
could also exist as the “free” nitroso group (Scheme 44).  It is also curious if this “free” nitroso 
group is part of the catalytic cycle.  To test this, 2-nitrosoaminobenzene (157) was prepared 
according to Haddadin et al38 and then reacted with 2-methylpropanal (55) in DMF at 80 °C.  
This reaction produced only 2-isopropylbenzimidazole (158) in 16% yield (Scheme 45).  This 
result indicates that the “free” nitroso group is not part of the catalytic cycle in the reactions 
forming quinoxalines and 2-quinoxalinones. 
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Scheme 44.  Illustration of 140 as an Aryl Nitroso Group 
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Scheme 45.  Reaction of 2-Nitrosoaminobenzene with 2-Methylpropanal 
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2.  Conclusions 
 We have proposed a reasonable mechanism for the palladium-catalyzed N-
heteroannulation of N-(2-nitroaryl)enamines to quinoxalines and 2-quinoxalinones that involves 
the formation of a palladium-bound nitrene as a key step.  We have designed several experiments 
to test the viability of our proposed mechanism and the results of all of them have been in 
support. 
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Part IV 
 
Novel Synthesis of 2-Alkylbenzimidazoles 
 
 
1.  Introduction 
 The benzimidazole nucleus is present in many physiologically active compounds.  
Examples of benzimidazoles possessing biological activity are omeprazole, an antiulcerative 
marketed by AstraZeneca under the names Prilosec (racemic) and Nexium (magnesium salt of 
the S-isomer), and thiabendazole, a veterinary anthelmintic and fungicide for spoilage control of 
citrus fruit and for the prevention of Dutch elm disease (Figure 3).  Other benzimidazoles exhibit 
antifertility,39 antitumor,40 anthelmintic,41 fungicidal,42 antiviral43 and antiarrhythmic44 activity.  
This variety of physiological activity makes the benzimidazole ring structure a worthwhile 
synthetic target for researchers. 
 
Figure 3.  Omeprazole and Thiabendazole 
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 A wide variety of synthetic methods for the preparation of benzimidazoles have been 
reported.  Bárzana et al reports the synthesis of benzimidazoles (161) and 1-
hydroxybenzimidazoles (160) from 4-alkyl-2-nitroacetanilides (159) by reductive cyclization 
with baker’s yeast (Scheme 46).45  The ortho nitro group of 159 is reduced by the yeast to the 
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corresponding hydroxylamine which then undergoes an intramolecular reaction with the amide 
carbonyl to give the 1-hydroxybenzimidazole (160).  The hydroxylamine could also undergo a 
second reduction to the amine, which then undergoes an analogous cyclization to the 
benzimidazole (161).  Interestingly, when the substituent on the aryl ring is a nitro group (R = 
NO2), only the nitro in the ortho position is reduced.  High conversion rates are generally 
associated with this reaction.  However, a potential drawback is that the reaction only works 
when the substituent is an electron withdrawing group. 
 
Scheme 46.  The Work of Bárzana et al 
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 It has been shown by Grenda et al that the reaction of N-arylamidine hydrochlorides 
(162) with sodium hypochlorite and base form benzimidazoles (163) in moderate to good yield 
(Scheme 47).46  This sequence can be used to form 2-alkyl and 2-arylbenzimidazoles with better 
yields generally accompanying the latter.  These reactions require the formation of an amidine 
from the reaction of an aryl amine with a nitrile or an imidate prior to cyclization.  A possible 
 47
drawback of this procedure is that if the aryl ring were substituted the cyclization will most likely 
give regioisomeric products. 
 
Scheme 47.  The Work of Grenda et al 
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 The synthesis of 2-alkylbenzimidazoles by TiO2-mediated photocatalysis is reported by 
Li et al.  In this example, alcoholic solutions of 1,2-dinitrobenzenes (164) are irradiated in the 
presence of TiO2 to form 2-alkylbenzimidazoles (165) in good yield (Scheme 48).47  The 
reaction involves the oxidation of the alcohol solvent to the corresponding aldehyde and the 
reduction of the dinitrobenzene to a 2-nitroaminobenzene.  This is followed by intermolecular 
condensation to form the corresponding imine.  Further reduction of the nitro group on the imine 
to the hydroxylamine followed by intramolecular cyclization and dehydration gives 2-
alkylbenzimidazoles.  Solvents, and therefore aldehydes, were limited to ethanol and 1-propanol 
to give methyl and ethyl substituted benzimidazoles, respectively.  It seems that this procedure is 
limited to alcohols that serve as good solvents for the reaction.  Also, substrates possessing an 
electron withdrawing group tended to give lower yields of benzimidazoles. 
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Scheme 48.  The Work of Li et al 
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 Another transition metal-catalyzed preparation of benzimidazoles is reported by Perry et 
al.48  In this sequence, described in Scheme 49, aryl halides (166) are reacted with 1,2-
diaminobenzenes (30) in the presence of carbon monoxide, a palladium catalyst and a base to 
form 2-arylbenzimidazoles (167) in good yields.  This procedure tolerates a variety of functional 
groups on either of the aromatic rings.  Some side products are seen in the reaction, such as 
bisamides, resulting from the reaction of both amino groups with two Ar-C(O)-Pd-X species.  
However, these products seem to be sufficiently diminished or eliminated by changing the base 
or solvent. 
 
Scheme 49.  The Work of Perry et al 
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 Thomas et al reported the synthesis of benzimidazoles by the tin(II) chloride reduction of 
2-nitroaminobenzenes followed by condensation with alkanoic anhydrides (Scheme 50).49  For 
example, fluoro substituted 2-nitroaminobenzene 168 is reduced with SnCl2 followed by the 
reaction with pentanoic anhydride to give the corresponding benzimidazole (169) in 48% yield.  
The low yield of this reaction along with the need for 5 equivalents of SnCl2 does not serve to 
make this method of benzimidazole preparation the most efficient. 
 
Scheme 50.  The Work of Thomas et al 
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 The reaction of 1,2-diaminobenzenes (30) with aliphatic selenonesters (170) to produce 
2-alkylbenzimidazoles (171) is reported by Cohen et al.50  This method is described in Scheme 
51.  The reaction proceeds smoothly in the unsubstituted system as well as with an electron 
donating substituent (R = CH3) on the aryl ring to afford the corresponding 2-alkybenzimidazole 
in 92% and 86% yields, respectively.  However, the yield of the reaction drops sharply with an 
electron withdrawing group (R = Cl) on the aryl ring.  Another potential drawback of this 
method is the production of moderately toxic hydrogen selenide as a byproduct. 
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Scheme 51.  The Work of Cohen et al 
 
R1 NH2
NH2
30
+ R2 OCH2CH3
Se
EtOH
ambient temp. N
N
H
R1
R2 + H2Se
170 171
R1 171
H
CH3
Cl
n-pentyl
n-propyl
n-pentyl
92%
86%
50%
R2
 
 
 A ruthenium-catalyzed route to benzimidazoles is reported by Cenini et al (Scheme 52).51  
The reaction of 2-nitroaminobenzene (52) with aliphatic or aromatic aldehydes (172) in the 
presence of Ru3(CO)12 (2.5 mol%) and carbon monoxide (49 atm) gives 2-alkyl and 2-
arylbenzimidazoles (163) in moderate to good yield.  The reaction is proposed to proceed 
through an imine intermediate followed by the formation of a ruthenium-bound nitrene.  The 
nitrene then inserts into the C-H bond of the imine to form the benzimidazole. 
 
Scheme 52.  The Work of Cenini et al 
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 Another route to benzimidazoles that probably proceeds through a nitrene intermediate is 
the reductive cyclization of N-benzilidene-2-nitroaminobenzenes (173) by triethyl phosphite 
(Scheme 53).  The formation of a nitrene species by phosphorus-promoted deoxygenation of 
aromatic nitro compounds has been proposed.30  This reaction, reported by Cadogan et al,52 
forms 2-phenylbenzimidazoles (174) in moderate to low yields. 
 
Scheme 53.  The Work of Cadogan et al 
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 The thermolysis of aromatic azides is also known to form nitrenes.30  The work of Hall et 
al53 is described in Scheme 54.  In this sequence, imines (177) are prepared in moderate to good 
yields by the reaction of 2-azidoaminobenzenes (175) with aromatic aldehydes (176).  
Thermolysis of these azido imines at 130 °C in DMF presumably forms the nitrene intermediate, 
which undergoes C-H insertion to form the 2-arylbenzimidazoles (178).  The two-step yields in 
these reactions are generally moderate to low. 
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Scheme 54.  The Work of Hall et al 
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 There are many different methods of forming the benzimidazole ring system.  Many of 
these methods are not without limitations.  Some require the multi-step formation of a 
cyclization precursor which lowers overall yields.  Many methods are intolerant of certain 
functional groups.  We have developed an extremely mild single-step route to 2-
alkylbenzimidazoles via sequential condensation-nitrene insertion reactions.  Our method 
tolerates a variety of substituents (electron-donating and withdrawing) as well as different 
substitution patterns.  Also, our reactions typically give 2-alkylbenzimidazoles in moderate to 
good yields.  The novel synthesis of a variety of 2-alkylbenzimidazoles is presented. 
 
2.  Results and Discussion 
 Encouraged by the results of the reaction described in Scheme 40 (Part III), we decided to 
pursue the preparation of 2-alkylbenzimidazoles by reacting 2-azidoaminobenzenes with 
aldehydes in refluxing ethanol.  It was necessary to first prepare a number of substituted 2-
azidoaminobenzenes.  Compounds 186 and 150 were prepared by the method of Hall et al 
(Scheme 55).54  First, the appropriate 2-nitroaminobenzenes (65 and 63) were melted with 
phthalic anhydride (179) to form the corresponding 2-phthalamidonitrobenzenes (180 and 181).  
Despite the relatively low yields of these reactions we decided to move forward in the sequence.  
 53
Subsequent reduction of 180 and 181 by iron and acetic acid produced 182 and 183, respectively, 
in good yields.  Next, the 2-phthalamidoaminobenzenes (182 and 183) were subjected to 
diazotization conditions followed by treatment with sodium azide.  This sequence produced 2-
phthalamidophenylazides 184 and 185 in 75% and 59% yields, respectively.  The final step of 
the series was the removal of the phthalamide protecting group.  This was performed using 
hydrazine hydrate and gave compounds 186 and 150 in 54% and 62% yields, respectively. 
 
Scheme 55.  Preparation of 186 and 150 
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 Due to the low yields of some of the reactions, namely on the first and last steps, we 
decided to modify the protocol for the formation of our 2-azidoaminobenzenes.  The formation 
of compounds 152, 197 and 198 was achieved a little differently (Scheme 56).  The appropriate 
o-aminonitroarenes (59, 67 and 86) were reacted with phthaloyl chloride (187) and pyridine in 
refluxing toluene to give the corresponding o-phthalamidonitroarenes (188, 189 and 190) in 
excellent yields.  Subsequent hydrogenation using 10% Pd/C as the catalyst afforded o-
aminophthalamidoarenes 191, 192 and 193 in 88%, 75% and 50% yields, respectively.  The 
hydrogenation reactions seemed to proceed more smoothly and cleaner than the iron reductions 
discussed above.  Compounds 191, 192 and 193 were then subjected to slightly modified 
diazotization conditions and treatment with sodium azide to give o-azidophthalamidoarenes 
(194, 195 and 196) in acceptable yields.  Also slightly modified were the deprotection reactions.  
These reactions worked better with longer reaction times and using THF/ethanol as co-solvents.  
Compounds 152, 197 and 198 were prepared according to this improved method in 98%, 60% 
and 96% yields, respectively. 
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Scheme 56.  Preparation of 152, 197 and 198 
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 With several compounds in hand, it was now possible to examine the scope of the 
benzimidazole-forming reaction.  During the condition optimization process, we tried several 
approaches.  The set of conditions that generally provided the highest benzimidazole yields are 
as follows:  1.0 equivalent of azide and 1.2 equivalents of aldehyde (added dropwise to avoid 
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aldol condensation side products) in refluxing ethanol for 24 h.  Shorter reaction times led to 
lower conversion to benzimidazoles and the isolation of azide starting materials.  We also 
attempted to promote the formation of imines by the addition of glacial acetic acid to the reaction 
mixture.  Generally, the addition of acid led to the rapid decomposition of the azides and, 
therefore, lower yields of benzimidazoles. 
 Next, we reacted our previously prepared azides with a variety of aldehydes under these 
“optimized” reaction conditions.  The results of these reactions are summarized in Table 6.  
Generally, the reactions of azides with 2-methylpropanal (55) and heptanal (83) proceeded 
smoothly to give 2-alkylbenzimidazoles in moderate yields.  However, the reactions of azides 
with some of the other aldehydes were met with limited success.  The reaction of 152 with 
phenylacetaldehyde (81) (Table 6, Entry 6) gave only 10% of the benzyl-substituted 
benzimidazole (202), while 203 was formed in 40% yield.  The product ratio changed somewhat 
when glacial acetic acid (25 µL) was added to the reaction mixture.  In this reaction 202 and 203 
were formed in 19% and 30% yields, respectively.  The reaction of 152 with 
trimethylacetaldehyde (205) (Table 6, Entry 8) formed 5-methyl-2-tert-butylbenzimidazole in 
25% yield.  This diminished yield may be attributed to the steric bulk around the electrophilic 
carbonyl.  In the reaction of 198 with 2-methylpropanal (55), the major product is 2,3-
diaminopyridine (213), presumably from the hydrogen abstraction of the nitrene intermediate.  
Imidazopyridine 212 is the minor product in this reaction, isolated in only 7% yield (Table 6, 
Entry 12). 
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Table 6.a  Synthesis of 2-Alkylbenzimidazoles 
 
Entry Azide Aldehyde Product(s)
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Cl Cl
N
N
H
CH3
CH3
Cl
Cl
N
N
H
C6H13H
O
83
Cl
H
CH3
CH3
O
55
H3C
N
N
H
CH3
CH3
H
O
83
H3C
N
N
H
C6H13
55
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Table 6 (continued) 
 
Entry Azide Aldehyde Product(s)
6c
7
8
9
NH2
N3
H
Ph
O
81152 202 (10%)
203 (40%)
152 203 (18%)
152
206 (25%)
152
208 (33%)
H3C
N
N
H
Bn
H3C
N
N
H
204
205
H3C
N
N
H
H CH3
O
207
H3C
N
N
H
CH3
H3C
+
CH2O
H
O CH3
CH3
CH3
CH3
CH3
CH3
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Table 6 (continued) 
 
Entry Azide Aldehyde Product(s)
10
NH2
N3
H
O
209152 210 (14%)
NH2
N3
197 136 (69%)
211 (8%)
N NH2
N3
198 212 (7%)
213 (33%)
N
N
H
N
N
H
CH3
N
N
H
55
N
N
N
H
CH3
CH3
N
H
CH3
CH3
O
55
H3C
CH3
CH3
CH3
CH3
CH3
+
NH2
NH2
+
a) General conditions: 1.0 eq azide, 1.2 eq aldehyde, ethanol, reflux, approx. 24 h.  b) An additional 
reaction was performed using 2.75 eq aldehyde and 0.5 mL acetic acid; yield: 151 (61%).  
c) An additional reaction was performed with 0.025 mL acetic acid added to reaction mixture; yields: 
202 (19%), 203 (30%)
11
12
H3C
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 The thermal reactions of 2-azidoaminobenzenes with aldehydes to form benzimidazoles 
are thought to occur by the mechanism described in Scheme 57.  At least initially, the reaction is 
thought to form an imine from the condensation of an amine and an aldehyde.  This is followed 
by the thermally-driven loss of N2 to give a nitrene.30  The imine-nitrene may then react in an 
electrocyclic fashion followed by spontaneous isomerization to form the benzimidazole.  In some 
of our reactions, benzimidazoles unsubstituted in the 2-position were obtained (Table 6, Entries 6 
and 11).  The reason for the formation of these products is unclear at this point. 
 
Scheme 57.  Proposed Mechanism for the Formation of Benzimidazoles 
 
                  
N
N
R
214
N
N
H
R
215
N
N
H
R
163  
 
 As a study of the mechanism of the formation of benzimidazoles, we attempted to 
prepare a 2-cyclopropylmethylbenzimidazole.  Our thought was that if a radical mechanism 
existed, one of the intermediates might react in such a way causing the cyclopropyl ring to open.  
Examination of the product(s) might give us some insight into the structure(s) of the 
intermediate(s).  A slightly different procedure was employed in the synthesis of 2-
cyclopropylmethyl-5-methylbenzimidazole (217) (Scheme 58).  First, 2-cyclopropylethanol 
(216) was oxidized to the aldehyde with pyridinium chlorochromate.  Without purification, to the 
aldehyde solution was added 2-azido-4-methylaminobenzene (152) and the mixture was heated 
at 100 °C in a sealed reaction vessel for 24 h.  This method, gave only benzimidazole 217 in 11% 
yield.  No other products were recovered and so no insight into the mechanism was gained. 
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Scheme 58.  Synthesis of 217 
 
          
OH
1) PCC, CH2Cl2, ambient temp.
2) 152, CH2Cl2, 100oC N
NH3C
H
216 217 (11%)  
 
3.  Conclusions 
 We have developed a novel route to 2-alkylbenzimidazoles from the condensation-
cyclization reaction of 2-azidoaminobenzenes and aldehydes.  The best results were achieved 
when 2-methylpropanal or heptanal was used.  Other aldehydes gave considerably lower yields 
of benzimidazoles.  The reaction can also be expanded to include the pyridine moiety; however, 
the yield was greatly diminished.  We have also proposed a mechanism for the transformations to 
occur involving a nitrene intermediate. 
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Part V 
 
Synthesis of Other Heterocyclic Ring Systems via N-Heteroannulation 
Reactions 
 
 
1.  Synthesis of Alloxazines 
 The family of compounds known as the alloxazines is characterized by the ring system 
shown in Figure 4.  Many members of this class of compounds exhibit a wide range of biological 
activity.55  One of the more notable biologically active alloxazines is the nutritional factor 
riboflavine.  It was our desire to expand the palladium-catalyzed N-heteroannulation 
methodology to include the synthesis of alloxazines. 
 
Figure 4.  Alloxazine and Riboflavine 
 
                         alloxazine
N O
N
O
N
N
N
N
N
NH3C
H3C
CH2
O
O
H
HO H
HO H
HO H
CH2OH
riboflavine
H
H
 
 
 In order to test our reaction conditions, it was necessary to synthesize the cyclization 
precursors.  Cyclization precursors would generally have to fit the model shown in Figure 5.  We 
attempted many methods in our quest to synthesize compounds of this type; however, in the end, 
we were unable to succeed at our task.  Various attempted procedures are presented. 
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Figure 5.  General Structure of an Alloxazine Precursor 
 
                                                              
N
O
N
O
N
R R
R
NO2
cyclization precursor  
 
 First we attempted to prepare a cyclization precursor by various reactions of 2-
nitroaminobenzene (52) and 6-halouracils (Scheme 59).  The details of these reactions are 
summarized in Table 7.  Addition-elimination type reactions were attempted with 52 and 6-
chlorouracil (218) using two different solvents, 1-butanol and chloroform (Table 7, Entries 1 and 
2).  Neither reaction produced the desired product.  Next, we attempted the coupling by 
following a literature protocol using N,N-dimethylaminobenzene and acetic acid.56  We tried this 
reaction using the chloro, bromo and iodo-substituted uracil (Table 7, Entries 3, 4 and 5).  None 
of these reactions were successful.  Finally, a copper-promoted coupling was attempted 
according to a literature procedure (Table 7, Entry 6).57  In this example, the coupling of 52 and 
218 failed to give the desired result. 
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Scheme 59.  General Reaction of 2-Nitroaminobenzene and 6-Halouracils 
 
               
NH2
NO2
N
N
+
R
CH3
O
CH3
O
various conditions no reaction
52  
 
Table 7.  Conditions for the Reactions of 2-Nitroaminobenzene and 6-Halouracils 
 
       
Entry Conditions
N
NR
CH3
O
CH3
O
218, R=Cl
218, R=Cl
218, R=Cl
219, R=Br
220, R=I
218, R=Cl
1-butanol, pyridine, reflux
CHCl3, pyridine, reflux
PhN(CH3)2, AcOH, 180oC
PhN(CH3)2, AcOH, 180oC
PhN(CH3)2, AcOH, 180oC
Cu, Li2CO3, DMSO, 150oC
1
2
3
4
5
6
 
 
 Next, a series of palladium-catalyzed reactions were attempted according to literature 
protocols (Scheme 60).58  The details of these reactions are summarized in Table 8.  The reaction 
of 2-nitroaminobenzene (52) with 6-iodouracil (220) under these conditions failed to give the 
desired product (Table 8, Entry 1).  When we attempted the coupling using 6-aminouracil (222) 
and aryl halides, the reactions failed as well (Table 8, Entries 2 and 3). 
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Scheme 60.  General Palladium-catalyzed Reactions to Form Cyclization Precursors  
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Table 8.  Conditions for the Palladium-catalyzed Reactions 
 
  
Entry Conditions
N
NZ
CH3
O
CH3
O
220, Z=I
222, Z=NH2
222, Z=NH2
Pd(dba)2, BINAP, KOt-Bu, toluene, 80oC
Pd(OAc)2, BINAP, Cs2CO3, toluene, 80oC
Pd(OAc)2, BINAP, Cs2CO3, toluene, 80oC
1
2
3
Y
X
NO2
52, X=NH2, Y=H
221, X=I, Y=H
223, X=Br, Y=OCH3
 
 
 It was necessary to synthesize three different 6-halouracils for the previously described 
coupling reactions.  Scheme 61 describes the syntheses of 6-chlorouracil (218), 6-iodouracil 
(220) and 6-bromouracil (219).  Compound 218 was prepared by the reaction of 1,3-
dimethylbarbituric acid (224) with phosphorus oxychloride in 78% yield.  Compound 220 was 
prepared in 64% yield from the reaction of 218 and sodium iodide. This reaction was performed 
in a sealed pressure tube in acetone at 120 °C.  The reaction of 1,3-dimethylbarbituric acid (224) 
with phosphorus tribromide gave compound 219 in 33% yield. 
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Scheme 61.  Preparation of 218, 219 and 220 
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 The synthesis of cyclization precursors was attempted by a few other methods, as well.  
Scheme 62 describes three such methods.  First, it was thought that the reaction of 2-
nitroaminobenzene (52) and 1,3-dimethylbarbituric acid (224) would produce the desired 
product by the condensation of the amino group and one of the less hindered carbonyls.  This 
reaction, however, failed to give the product.  The reaction of 2-nitroaminobenzene (52) and 6-
aminouracil (222) under acidic conditions was thought would proceed through an addition-
elimination pathway and result in the formation of the desired product and ammonia.  This 
reaction, too, failed.  Finally, we proposed that the reaction of 2-azidonitrobenzene (131) with 
triphenylphosphine would form the corresponding iminophosphorane.  This species would then 
react in an aza-Wittig fashion with one of the less hindered carbonyls to form the desired 
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compound.  When the reaction was performed in tetrahydrofuran (THF), the only product 
isolated from this sequence was 2-nitroaminobenzene (52) in 94% yield.  However, when diethyl 
ether was used for the formation of the iminophosphorane, then CHCl3 for the aza-Wittig, no 
reaction occurred. 
 
Scheme 62.  Other Reactions to Form Cyclization Precursors 
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2.  Synthesis of an Indole-fused Pyrimidine Derivative 
 Heterocyclic compounds having the general structure shown in Figure 6 are known to 
exhibit physiological properties such as blood sugar-lowering activity.59  It was our desire to 
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explore the possibility of preparing such compounds using our palladium-catalyzed N-
heteroannulation method. 
 
Figure 6.  General Structure of an Indole-fused Pyrimidine Derivative 
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 In order to test the reaction, we first needed to synthesize an appropriate cyclization 
precursor.  We chose to prepare our precursor via a Stille coupling of tributyl(2-
nitrophenyl)stannane (225) and 6-iodouracil (220) (Scheme 63).  Aryl stannane 225 was 
previously synthesized in our labs according to a literature procedure.60  The reaction of 225 and 
220 in the presence of PdCl2(PhCN)2, Ph3As and CuI in N-methylpyrrolidinone (NMP) at 80 °C 
gave the desired coupling product 226 and homocoupling product 227 in 48% and 36% yields, 
respectively. 
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Scheme 63.  Preparation of 226 and 227 
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 With compound 226 in hand, we attempted the cyclization according to our method.  The 
reaction of 226 in the presence of Pd(dba)2, dppp, phen and carbon monoxide in DMF at 70 °C 
gave the desired cyclization product 228 in 9% yield (Scheme 64). 
 
Scheme 64.  Synthesis of 228 
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3.  Conclusions 
 Despite numerous attempts and the use of many different methods we were unsuccessful 
in the synthesis of alloxazine precursors.  It is our belief that if this type of compound can be 
prepared that it will undergo cyclization under our conditions to form the desired alloxazine.  
More research is planned in this area. 
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 We were able to synthesize an interesting heterocyclic compound that is analogous to 
compounds known to exhibit biological activity.  This compound was synthesized in relatively 
low yield; however, with adjustments to the protocol, it is our belief that our method of 
cyclization can be expanded and become a viable synthetic route to compounds of this type.  
This is an area that will be researched further in our labs. 
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Part VI 
 
Experimental Section 
 
 
1.  General Procedures 
 
 All NMR spectra were determined in CDCl3 at 270 MHz (1H NMR) and 67.5 MHz (13C 
NMR) unless otherwise noted.  The chemical shifts are expressed in δ values relative to (CH3)4Si 
(0.00, 1H and 13C) or CDCl3 (7.26, 1H and 77.00, 13C) internal standards.  1H-1H coupling 
constants are reported as calculated from spectra; thus, a slight difference in Ja,b and Jb,a is 
usually obtained.  Results of APT (attached proton test) 13C NMR experiments are shown in 
parentheses, where relative to CDCl3, (-) denotes CH3 or CH and (+) denotes CH2 or C. 
 Benzene, toluene and diethyl ether were distilled from sodium benzophenone ketyl prior 
to use.  Pyridine, triethylamine, hexanes, acetonitrile, ethyl acetate and dichloromethane were 
distilled from calcium hydride.  Chemicals prepared according to literature procedures have been 
referenced the first time they are used; all other reagents were obtained from commercial sources 
and used as received.  Silica gel (200-400 mesh) was used for flash chromatography.  Solvents 
were removed using a rotary evaporator at water aspirator pressure unless otherwise noted.  
Infrared (IR) spectra were recorded using NaCl plates.  Elemental analyses were performed by 
Atlantic Microlab, Inc., Norcross, GA.  High Resolution Mass Spectra (HRMS) were performed 
at the University of California Riverside Mass Spectrometry Center. 
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2.  Experimental Details 
 
Methyl 2-bromomethyl-3-nitrobenzoate7 (18). 
 To a solution of methyl 2-methyl-3-nitrobenzoate (17) (9.60 g, 49.1 mmol) and benzoyl 
peroxide (0.60 g, 2.6 mmol) in CCl4 (100 mL) was added dropwise a solution of bromine (3.0 
mL, 58.6 mmol) dissolved in CCl4 (20 mL) with stirring.  The mixture was illuminated with a 
100 Watt flood lamp and was heated at reflux for 24 h.  The reaction was diluted with CH2Cl2 
(50 mL) and washed with NaHCO3 (saturated, aqueous, 3 X 50 mL).  The organic phase was 
dried (MgSO4), filtered and concentrated.  Compound 18 (13.46 g, 49.1 mmol, 100%) was 
obtained as pale yellow crystals. 
 
(2-Carbomethoxy-6-nitrobenzyl)triphenylphosphonium bromide7 (19). 
 To a solution of 18 (13.50 g, 49.1 mmol) in CHCl3 (150 mL) was added 
triphenylphosphine (14.80 g, 56.5 mmol) with stirring.  The reaction was heated at reflux for 2 h.  
The resulting orange solution was then poured into diethyl ether (anhydrous, 400 mL) and a 
white precipitate formed.  After cooling in the freezer (approx. -20 °C) for 1 h, (2-carbomethoxy-
6-nitrobenzyl)triphenylphosphonium bromide (19) was collected by filtration and used without 
further purification in the next procedure. 
 
Methyl 2-ethenyl-3-nitrobenzoate7 (20). 
 Paraformaldehyde (20.00 g, 667 mmol) was placed in a 250 mL, 2-necked, round-
bottomed flask.  An argon inlet was connected to one of the necks.  The other neck was 
connected to a 1 L, 2-necked, round-bottomed flask via Tygon tubing (2 cm id) and two male 
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24/40 joints.  In the 1 L flask, the crude (2-carbomethoxy-6-nitrobenzyl)triphenylphosphonium 
bromide from the previous procedure was dissolved in CH2Cl2 (500 mL).  A glass tube was 
attached to the Tygon tubing such that the end extended several cm into the solution.  
Triethylamine (30.0 mL, 215 mmol) was added to the 1 L flask and resulted in the immediate 
formation of a deep blue/purple solution; a condenser was attached to the second neck of the 
flask.  Argon was then passed over the paraformaldehyde so that a steady stream of gas was 
constantly bubbling through the purple ylide solution.  The paraformaldehyde was then heated to 
160 °C in order to generate formaldehyde which flowed through the solution.  Upon completion 
of the addition of formaldehyde, the purple color of the ylide slowly changed to brown over a 
period of 1-2 h.  The resulting solution was poured into hexanes (500 mL) and the resulting solid 
(triphenylphosphine oxide) was removed by filtration.  The filtrate was concentrated and the 
crude product was purified by flash chromatography (hexanes/EtOAc, 8:2) to give 20 (7.30 g, 
35.0 mmol, 71% over 2 steps) as a white solid. 
 
Methyl indole-4-carboxylate7, 10 (21). 
 To a solution of 20 (4.10 g, 20.0 mmol) and triphenylphoshine (1.30 g, 4.8 mmol) 
dissolved in acetonitrile (100 mL) in a 300 mL glass liner of a stainless steel reaction vessel was 
added palladium diacetate (269 mg, 1.2 mmol).  The glass liner was placed in the reaction vessel 
and the vessel was flushed 3 times with CO.  The reaction was heated and stirred at 90 °C under 
CO (6 atm) for 27 h.  The reaction mixture was filtered through Celite and washed with CH2Cl2.  
The filtrate was concentrated and the product was purified by flash chromatography 
(hexanes/CH2Cl2, 7:3, then 1:1) to give 21 (3.06 g, 17.5 mmol, 87%) as a pale yellow solid. 
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2-Nitro-N-[(4-nitrophenyl)methylene]benzenamine61 (54). 
 To a solution of 2-nitroaminobenzene (52) (502 mg, 3.6 mmol) and 4-nitrobenzaldehyde 
(53) (552 mg, 3.7 mmol) dissolved in benzene (anhydrous, 10 mL) under argon atmosphere was 
added 4 Å molecular sieves (3 g; the molecular sieves were charged by heating to 120 °C under 
vacuum overnight and then stored under argon atmosphere).  The reaction proceeded at ambient 
temperature without stirring for 23 h.  The molecular sieves were removed by filtration and then 
rinsed with CH2Cl2.  The filtrate was concentrated and the product was recrystallized from 
EtOAc to give 54 (532 mg, 1.96 mmol, 54%) as a fluffy yellow solid:  1H NMR δ 8.51 (s, 1 H), 
8.36 (d, J = 8.7 Hz, 2 H), 8.09 (d, J = 8.7 Hz, 2 H), 8.02 (dd, J = 8.1 and 1.4 Hz, 1 H), 7.64 (dt, J 
= 7.9 and 1.4 Hz, 1 H), 7.38 (dt, J = 7.8 and 1.2 Hz, 1 H), 7.08 (d, J = 7.9 Hz, 1 H);  13C NMR δ 
159.3 (-), 149.6 (+), 145.8 (+), 142.8 (+), 140.5 (+), 134.1 (-), 129.9 (-), 126.3 (-), 124.8 (-), 
124.0 (-), 120.5 (-). 
 
2-Nitro-N-[(2-methyl)-1-propenyl]benzenamine (56). 
 To a solution of 2-nitroaminobenzene (52) (502 mg, 3.6 mmol) and 2-methylpropanal 
(55) (0.33 mL, 3.6 mmol) dissolved in benzene (anhydrous, 10 mL) at -20 °C under argon 
atmosphere was added 4 Å molecular sieves (4 g; the molecular sieves were charged by heating 
to 120 °C under vacuum overnight and then stored under argon atmosphere).  The reaction 
proceeded at -20 °C for 14 days.  The molecular sieves were removed by filtration and then 
rinsed with CH2Cl2.  The filtrate was concentrated and the product was purified by flash 
chromatography (hexanes/EtOAc, 95:5) to give 56 (510 mg, 2.7 mmol, 73%) as a red solid:  mp 
38-40°C;  1H NMR δ 9.64 (br s, 1 H), 8.18 (dd, J = 8.4 and 1.5 Hz, 1 H), 7.44 (dt, J = 8.6 and 1.5 
Hz, 1 H), 7.05 (d, J = 8.7 Hz, 1 H), 6.70 (dt, J = 6.9 and 1.2 Hz, 1 H), 6.27 (dm, J = 8.2 and 1.2 
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Hz, 1 H), 1.82 (s, 3 H), 1.80 (s, 3 H);  13C NMR δ 141.3 (+), 136.0  (-), 131.6 (+), 126.7 (-), 
118.4 (+), 118.2 (-), 116.3 (-), 114.1  (-), 22.5 (-), 16.6 (-);  IR (neat) 1639, 1577, 1208 cm-1;  
HRMS (EI) calc. for C10H12N2O2 192.0899, found 192.0899. 
 
1,2-Dihydro-2,2-dimethylquinoxaline62 (57) and 3,4-dihydro-3,3-dimethyl-2-
quinoxalinone63 (58). 
 2-Nitro-N-[(2-methyl)-1-propenyl]benzenamine (56) (102 mg, 0.53 mmol), Pd(dba)2 (20 
mg, 0.035 mmol), 1,3-bis(diphenylphosphino)propane (dppp) (15 mg, 0.036 mmol) and 
acetonitrile (5 mL) were combined in a threaded pressure tube fitted with a pressure head.  The 
tube was flushed 3 times with CO.  The reaction was heated and stirred at 70 °C under CO (4 
atm) for 20 h.  The reaction mixture was filtered through Celite and washed with CH2Cl2.  The 
filtrate was concentrated and the product was purified by flash chromatography (hexanes/EtOAc, 
7:3) to give 57 (60 mg, 0.375 mmol, 71%) and 58 (10 mg, 0.057 mmol, 11%) as off-white solids. 
 
4-Methyl-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (60). 
 The same procedure as described for 56 was repeated except that a mixture of 4-methyl-
2-nitroaminobenzene (59) (501 mg, 3.3 mmol), 2-methylpropanal (55) (0.30 mL, 3.3 mmol), 
benzene (anhydrous, 10 mL) and 4 Å molecular sieves (4 g) at ambient temperature was reacted 
for 20 h.  Purification by flash chromatography (hexanes/EtOAc, 95:5) gave 60 (601 mg, 2.9 
mmol, 89%) as a red solid:  mp 53-55°C;  1H NMR δ 9.56 (br s, 1 H), 7.98 (s, 1 H), 7.27 (dd, J = 
8.6 and 2.2 Hz, 1 H), 6.96 (d, J = 8.9 Hz, 1 H), 6.27 (dm, J = 9.6 Hz, 1 H), 2.28 (s, 3 H), 1.81 (s, 
3 H), 1.79 (s, 3 H);  13C NMR δ 139.4 (+), 137.5 (-), 131.1 (+), 126.0 (+), 125.8 (-), 118.4 (-), 
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117.4 (+), 114.1 (-), 22.4 (-), 19.9 (-), 16.6 (-);  IR (neat) 1632, 1572, 1519, 1341, 1166 cm-1;  
Anal. calcd for C11H14N2O2: C, 64.06; H, 6.84, found: C, 64.18; H, 6.70. 
 
4-Methoxy-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (62). 
 The same procedure as described for 56 was repeated except that a mixture of 4-
methoxy-2-nitroaminobenzene (61) (506 mg, 3.0 mmol), 2-methylpropanal (55) (0.30 mL, 3.3 
mmol), benzene (anhydrous, 10 mL) and 4 Å molecular sieves (4 g) at ambient temperature was 
reacted for 20 h.  Purification by flash chromatography (hexanes/EtOAc, 98:2) gave 62 (635 mg, 
2.9 mmol, 95%) as a red solid: mp 57-59°C;  1H NMR δ 9.61 (d, J = 8.2 Hz, 1 H), 7.60 (d, J = 
2.7 Hz, 1 H), 7.15 (dd, J = 9.4 and 3.0 Hz, 1 H), 7.02 (d, J = 9.4 Hz, 1 H), 6.27 (dm, J = 9.6 Hz, 
1 H), 3.81 (s, 3 H), 1.81 (s, 3 H), 1.79 (s, 3 H);  13C NMR δ 150.2 (+), 137.0 (+), 130.6 (+), 127.1 
(-), 118.5 (-), 117.5 (+), 115.5 (-), 106.5 (-), 55.6 (-), 22.4 (-), 16.6 (-);  IR (neat) 1638, 1520, 
1162, 1122 cm-1;  Anal. calcd for C11H14N2O3: C, 59.45; H, 6.35, found: C, 59.18; H, 6.42. 
 
4-Chloro-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (64). 
 The same procedure as described for 56 was repeated except that a mixture of 4-chloro-2-
nitroaminobenzene (63) (505 mg, 2.9 mmol), 2-methylpropanal (55) (0.27 mL, 2.9 mmol), 
benzene (anhydrous, 10 mL) and 4 Å molecular sieves (4 g) at ambient temperature was reacted 
for 26 h.  No further purification was needed and 64 (660 mg, 2.9 mmol, 100%) was obtained as 
a red solid:  mp 109-110°C;  1H NMR δ 9.58 (d, J = 8.2 Hz, 1 H), 8.17 (d, J = 2.7 Hz, 1 H), 7.38 
(dd, J = 9.2 and 2.5 Hz, 1 H), 7.01 (d, J = 9.1 Hz, 1 H), 6.22 (dm, J = 9.6 and 1.2 Hz, 1 H), 1.82 
(s, 3 H), 1.79 (s, 3 H);  13C NMR δ 140.0 (+), 136.2 (-), 131.5 (+), 125.9 (-), 121.2 (+), 119.9 (+), 
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118.0 (-), 115.7 (-), 22.5 (-), 16.8 (-);  IR (neat) 1641, 1198, 1124 cm-1;  Anal. Calc for 
C10H11ClN2O2: C, 52.99; H, 4.89, found: C, 53.08; H, 4.82. 
 
5-Chloro-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (66). 
 The same procedure as described for 56 was repeated except that a mixture of 5-chloro-2-
nitroaminobenzene (65) (504 mg, 2.9 mmol), 2-methylpropanal (55) (0.30 mL, 3.3 mmol), 
CH2Cl2 (anhydrous, 15 mL) and 4 Å molecular sieves (4 g) at ambient temperature was reacted 
for 24 h.  No further purification was needed and 66 (585 mg, 2.6 mmol, 88%) was obtained as a 
red solid:  mp 99-100°C;  1H NMR δ 9.60 (br s, 1 H), 8.13 (d, J = 9.2 Hz, 1 H), 7.02 (d, J = 2.2 
Hz, 1 H), 6.66 (dd, J = 9.2 and 2.2 Hz, 1 H), 6.19 (d, J = 9.4 Hz, 1 H), 1.83 (s, 3 H), 1.79 (s, 3 
H);  13C NMR δ 142.8 (+), 141.8 (+), 130.3 (+), 128.2 (-), 120.5 (+), 117.8 (-), 116.9 (-), 113.8  
(-), 22.5 (-), 16.8 (-);  IR (neat) 3326, 3112, 2927, 1570, 1494, 1410, 1190, 1064 cm-1;  HRMS 
(EI) calc. for C10H11ClN2O2 226.0509, found 226.0500. 
 
6-Methyl-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (68). 
 To a solution of 2-methyl-6-nitroaminobenzene (67) (1.03 g, 6.8 mmol) and 2-
methylpropanal (55) (2.0 mL, 22.0 mmol) dissolved in 1,2-dichloroethane (20 mL) in a threaded 
pressure tube was added 4 Å molecular sieves until the level of the sieves was just below that of 
the solvent (the molecular sieves were charged by heating to 120 °C under vacuum overnight and 
then stored under argon atmosphere).  The pressure tube was capped tightly with a threaded 
Teflon plug.  The reaction was heated in a standard microwave oven for 30 seconds then allowed 
to cool for 3-5 minutes.  This was repeated until the total heating time reached 15 minutes.  The 
molecular sieves were removed by filtration and washed with CH2Cl2.  The filtrate was 
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concentrated and the product was purified by flash chromatography (hexanes/EtOAc, 9:1) to 
give 68 (71 mg, 0.34 mmol, 5%) as a red paste:  1H NMR δ 8.75 (d, J = 5.9 Hz, 1 H), 7.95 (d, J = 
8.6 Hz, 1 H), 7.30 (d, J = 7.4 Hz, 1 H), 6.76 (t, J = 7.7 Hz, 1 H), 5.98 (d, J = 8.4 Hz, 1 H), 2.40 
(s, 3 H), 1.76 (s, 3 H), 1.72 (s, 3 H);  13C NMR δ 141.5 (+), 138.2 (-), 137.3 (+), 129.4 (+), 124.2 
(-), 124.1 (-), 118.5 (-), 114.6 (+), 22.2 (-), 20.9 (-), 16.3 (-);  IR (neat) 1634, 1519, 1339 cm-1. 
 
2,4-Dinitro-N-[(2-methyl)-1-propenyl]benzenamine (70). 
 The same procedure as described for 68 was repeated except that a mixture of 2,4-
dinitroaminobenzene (69) (1.00 g, 5.5 mmol), 2-methylpropanal (55) (1.0 mL, 13.9 mmol) and 
1,2-dichloroethane (20 mL) was reacted for a total of 15 minutes.  Purification by flash 
chromatography (hexanes/EtOAc, 9:1) gave 70 (1.00 g, 4.3 mmol, 78%) as a red solid:  mp 113-
115°C;  1H NMR δ 10.06 (d, J = 8.2 Hz, 1 H), 9.16 (d, J = 2.5 Hz, 1 H), 8.27 (dd, J = 9.6 and 2.7 
Hz, 1 H), 7.12 (d, J = 9.6 Hz, 1 H), 6.32 (d, J = 9.4 Hz, 1 H), 1.88 (s, 3 H), 1.85 (s, 3 H);  13C 
NMR δ 143.8 (+), 136.5 (+), 130.0 (-), 129.9 (+), 124.1 (-), 124.0 (+), 117.0 (-), 114.4 (-), 22.5  
(-), 16.8 (-);  IR (neat) 1590, 1461, 1426, 1330, 1307 cm-1;  Anal. calcd for C10H11N3O4: C, 
50.63; H, 4.67, found: C, 50.79; H, 4.77. 
 
3-Methyl-2-nitroaminobenzene64 (71). 
 To a solution of 3-methyl-2-nitrobenzoic acid (84) (4.90 g, 27.0 mmol) dissolved in 1,2-
dichloroethane (100 mL) was added SOCl2 (10.0 mL, 137 mmol) and N,N-dimethylformamide 
(DMF) (1 drop).  The reaction refluxed under argon atmosphere for 3 h and was then 
concentrated by vacuum distillation.  The resulting material was added to acetone (75 mL, 0 °C).  
To this solution was added NaN3 (10.1 g, 155 mmol in 40 mL H2O) and the mixture stirred for 
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10 minutes.  This solution was added to H2O (300 mL) and the resulting solid (acyl azide) was 
collected by filtration and used without further purification. 
 The crude acyl azide was dissolved in AcOH/distilled H2O (10:1, 330 mL) and refluxed 
for 2 h.  The reaction was concentrated by vacuum distillation.  The resulting solid was 
recrystallized from AcOH to give 71 (2.48 g, 16.3 mmol, 60%):  1H NMR δ 7.14 (t, J = 7.7 Hz, 1 
H), 6.65 (d, J = 8.3 Hz, 1 H), 6.58 (d, J = 7.3 Hz, 1 H), 5.15 (br s, 2 H), 2.47 (s, 3 H);  13C NMR 
(150 MHz) δ 142.9 (+), 136.1 (+), 135.0 (+), 132.7 (-), 120.7 (-), 116.0 (-), 20.9 (-). 
 
3-Methyl-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (72). 
 The same procedure as described for 56 was repeated except that a mixture of 3-methyl-
2-nitroaminobenzene (71) (500 mg, 3.3 mmol), 2-methylpropanal (55) (0.50 mL, 5.5 mmol), 
benzene (anhydrous, 20 mL) and 4 Å molecular sieves (15 g) at ambient temperature was reacted 
for 3 days.  Purification by flash chromatography (hexanes) gave 72 (241 mg, 1.17 mmol, 36%) 
as a red paste:  1H NMR δ 8.24 (d, J = 8.4 Hz, 1 H), 7.23 (t, J = 7.9 Hz, 1 H), 6.84 (d, J = 8.6 Hz, 
1 H), 6.58 (d, J = 7.4 Hz, 1 H), 6.12 (d, J = 9.4 Hz, 1 H), 2.49 (s, 3 H), 1.78 (s, 3 H), 1.73 (s, 3 
H);  13C NMR δ 140.3 (+), 135.9 (+), 135.5, 133.3 (-), 120.5 (-), 119.4 (-), 116.8 (+), 112.3 (-), 
22.5  (-), 21.6 (-), 16.6 (-). 
 
[4-(2-Methylpropenylamino)-3-nitrophenyl]phenylmethanone (74). 
 The same procedure as described for 56 was repeated except that a mixture of 3-nitro-4-
aminobenzophenone (73) (500 mg, 2.1 mmol), 2-methylpropanal (55) (0.30 mL, 3.3 mmol), 
CH2Cl2 (anhydrous, 40 mL) and 4 Å molecular sieves (15 g) at ambient temperature was reacted 
for 12 days.  Purification by flash chromatography (hexanes/EtOAc, 9:1) gave 74 (120 mg, 0.41 
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mmol, 20%) as a red solid:  1H NMR δ 9.96 (d, J = 9.4 Hz, 1 H), 8.66 (d, J = 2.0 Hz, 1 H), 8.04 
(dd, J = 9.1 and 2.0 Hz, 1 H), 7.75 (dd, J = 8.4 and 1.5 Hz, 2 H), 7.60 (t, 1 H), 7.50 (t, 2 H), 7.14 
(d, J = 9.1 Hz, 1 H), 6.34 (d, J = 9.4 Hz, 1 H), 1.86 (s, 3 H), 1.84 (s, 3 H);  13C NMR δ 193.4 (+), 
143.4 (+), 137.4 (+), 136.8 (-), 132.3 (-), 130.7 (-), 130.5 (+), 129.4 (-), 128.5 (-), 125.5 (+), 
121.8 (+), 117.6 (-), 114.3 (-), 22.6 (-), 16.9 (-);  IR (neat) 1650, 1612, 1209, 1132  cm-1. 
 
Methyl 4-amino-3-nitrobenzoate65 (75). 
 Methanol (30.0 mL, 741 mmol), 4-amino-3-nitrobenzoic acid (85) (2.00 g, 11.0 mmol), 
H2SO4 (concentrated, 1.0 mL) and benzene (anhydrous, 100 mL) were combined in a round-
bottomed flask fitted with a Dean-Stark trap and a reflux condenser.  The reaction was heated 
and stirred at reflux for 13 h.  The reaction mixture was then concentrated and added to CHCl3 
(100 mL).  The solution was washed with NaHCO3 (20% aqueous solution, 2 X 100 mL).  The 
organic phase was dried (MgSO4), filtered and concentrated.  Purification by flash 
chromatography (hexanes/EtOAc, 9:1, 8:2 and 7:3) gave 75 (1.50 g, 7.6 mmol, 69%) as a yellow 
solid. 
 
Methyl 4-(2-methylpropenylamino)-3-nitrobenzoate (76). 
 The same procedure as described for 56 was repeated except that a mixture of methyl 4-
amino-3-nitrobenzoate (75) (500 mg, 2.6 mmol), 2-methylpropanal (55) (5.0 mL, 55.1 mmol), 
camphor sulfonic acid (10 mg), CH2Cl2 (anhydrous, 150 mL) and 4 Å molecular sieves (50 g) at 
ambient temperature was reacted for 11 days.  Purification by flash chromatography 
(hexanes/EtOAc, 95:5) gave 76 (470 mg, 1.88 mmol, 74%) as a red solid:  mp 121-124 °C;  1H 
NMR δ 9.87 (d, J = 11.4 Hz, 1 H), 8.89 (d, J = 2.0 Hz, 1 H), 8.05 (dd, J = 9.2 and 1.5 Hz, 1 H), 
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7.06 (d, J = 9.2 Hz, 1 H), 6.30 (d, J = 9.4 Hz, 1 H), 3.91 (s, 3 H), 1.85 (s, 3 H), 1.82 (s, 3 H);  13C 
NMR δ 165.4 (+), 143.4 (+), 136.1 (-), 131.0 (+), 129.4 (-), 121.2 (+), 118.1 (+), 117.6 (-), 113.9 
(-), 52.1 (-), 22.6 (-), 16.8 (-);  IR (neat) 1707, 1615, 1523, 1437, 1287, 1217 cm-1. 
 
4-Methoxy-2-nitro-N-(cyclohexylmethylene)benzenamine (78). 
 The same procedure as described for 56 was repeated except that a mixture of 4-
methoxy-2-nitroaminobenzene (61) (508 mg, 3.0 mmol), formylcyclohexane (77) (0.360 mL, 3.2 
mmol), benzene (anhydrous, 10 mL) and 4 Å molecular sieves (4 g) at ambient temperature was 
reacted for 2.5 h.  No further purification was needed and 78 (696 mg, 2.7 mmol, 88%) was 
obtained as a red solid:  mp 46-48°C;  1H NMR δ 9.68 (br s, 1 H), 7.60 (d, J = 2.7 Hz, 1 H), 7.15 
(dd, J = 9.4 and 3.2 Hz, 1 H), 7.05 (d, J = 9.2 Hz, 1 H), 6.22 (d, J = 9.4 Hz, 1 H), 3.81 (s, 3 H), 
2.30-1.50 (m, 10 H);  13C NMR δ 150.3 (+), 137.4 (+), 130.6 (+), 127.2 (-), 126.1 (+), 115.6 (-), 
115.5 (-), 106.6 (-), 55.7 (-), 33.6 (+), 28.3 (+), 27.5 (+), 26.9 (+), 26.6 (+);  IR (neat) 2929, 
2360, 1572, 1517, 1411, 1283, 1214 cm-1;  HRMS (EI) calc. for C14H18N2O3 262.1317, found 
262.1310. 
 
4-Methoxy-2-nitro-N-(2,2-diphenylethenyl)benzenamine (80). 
 The same procedure as described for 56 was repeated except that a mixture of 4-
methoxy-2-nitroaminobenzene (61) (304 mg, 1.8 mmol), diphenylacetaldehyde (79) (0.40 mL, 
2.3 mmol), CH2Cl2 (anhydrous, 30 mL) and 4 Å molecular sieves (15 g) at ambient temperature 
was reacted for 3 days.  Purification by flash chromatography (hexanes/EtOAc, 9:1) gave 80 
(572 mg, 1.7 mmol, 91%) as a red solid:  mp 152-153°C;  1H NMR δ 9.93 (d, J = 11.6 Hz, 1 H), 
7.53 (d, J = 2.7 Hz, 1 H), 7.48-7.05 (m, 13 H), 3.74 (s, 3 H);  13C NMR δ 151.3 (+), 140.7 (+), 
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137.4 (+), 135.1 (+), 132.2 (+), 129.7 (-), 129.3 (-), 128.4 (-), 127.9 (-), 126.6 (-), 126.5 (two 
overlapping peaks; both -), 124.0 (+), 121.6 (-), 115.8 (-), 107.4 (-), 55.8 (-);  IR (neat) 3055, 
1517, 1283, 1218, 1139, 1062 cm-1;  HRMS (EI) calc. for C21H18N2O3 346.1317, found 
346.1306. 
 
(E)-4-Chloro-2-nitro-N-(2-phenylethylene)benzenamine (82-E) and (Z)-4-chloro-2-nitro-N-
(2-phenylethylene)benzenamine (82-Z). 
 The same procedure as described for 56 was repeated except that a mixture of 4-chloro-2-
nitroaminobenzene (63) (1.00 g, 5.8 mmol), phenylacetaldehyde (81) (0.70 mL, 6.0 mmol), 
CH2Cl2 (anhydrous, 35 mL) and 4 Å molecular sieves (15 g) at ambient temperature was reacted 
for 20 h.  A virtually inseparable mixture of 82-E and 82-Z (1.35 g, 4.9 mmol, 85%) resulted as a 
red solid:  82-Z mp 104-106°C;  1H NMR δ 10.41 (d, J = 10.6 Hz, 1 H), 8.20 (d, J = 2.5 Hz, 1 
H), 7.50-7.40 (m, 5 H), 7.27 (tt, J = 6.9 and 1.7 Hz, 1 H), 7.18 (d, J = 9.2 Hz, 1 H), 6.64 (dd, J = 
11.1 and 9.4 Hz, 1 H), 5.83 (d, J = 9.2 Hz, 1 H);  13C NMR δ 138.9 (+), 136.3 (-), 135.2 (+), 
132.7 (+), 129.1 (-), 127.7 (-), 127.1 (-), 126.1 (-), 122.9 (+), 122.5  (-) 115.8 (-), 111.5 (-);  IR 
(neat) 3317, 2352, 1640, 1619, 1567, 1513, 1341 cm-1;  HRMS (EI) calc. for C14H11ClN2O2 
274.0509, found 274.0513;  82-E 1H NMR δ 9.87 (d, J = 11.9 Hz, 1 H), 8.14 (d, J = 2.5 Hz, 1 
H), 7.60-7.20 (m, 6 H), 7.06 (d, J = 15.8 Hz, 1 H), 6.98 (d, J = 11.4 Hz, 1 H), 6.16 (d, J = 15.6 
Hz, 1 H). 
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3-Nitro-N-[(2-methyl)-1-propenyl]-2-pyridinamine (87) and N-(1-(3-nitropyridin-2-
ylamino)-2-methylpropyl)-3-nitropyridin-2-amine (88). 
 The same procedure as described for 56 was repeated except that a mixture of 2-amino-3-
nitropyridine (86) (505 mg, 3.6 mmol), 2-methylpropanal (55) (0.35 mL, 3.9 mmol), CH2Cl2 
(anhydrous, 35 mL) and 4 Å molecular sieves (15 g) at ambient temperature was reacted for 5 
days.  Purification by flash chromatography (hexanes/EtOAc, 9:1) gave 87 (139 mg, 0.7 mmol, 
20%) as a red solid and 88 (258 mg, 0.8 mmol, 44%) as a yellow solid:  87 mp 62-64°C;  1H 
NMR δ 9.87 (br s, 1 H), 8.50-8.40 (m, 2 H), 7.08 (d, J = 8.2 Hz, 1 H), 6.80-6.60 (m, 1 H), 1.84 
(s, 3 H), 1.82 (s, 3 H);  13C NMR δ 155.8 (-), 148.4 (+), 135.4 (-), 127.6 (+), 117.3  (-), 116.8 (+), 
112.8 (-), 22.7 (-), 16.8 (-);  IR (neat) 3364, 2917, 1678, 1604, 1574, 1494, 1444 cm-1;  Anal. 
calcd for C9H11N3O2: C, 55.95; H, 5.74, found: C, 56.06; H, 5.69;  88 mp 101-103 °C;  1H NMR 
δ 8.81 (d, J = 7.9 Hz, 2 H), 8.45-8.35 (m, 4 H), 6.73-6.67 (m, 2 H), 6.29 (quartet, J = 7.6 Hz, 1 
H), 2.63 (octet, J = 6.9 Hz, 1 H), 1.11 (d, J = 6.7 Hz, 6 H);  13C NMR δ 155.2 (-), 151.7 (+), 
135.1 (-), 128.1 (+), 112.4 (-), 64.2 (-), 32.0 (-), 18.4 (-);  IR (neat) 3372, 1600, 1569, 1481, 
1443, 1245 cm-1. 
 
2-(2-Nitrophenylamino)-2-cyclohexen-1-one (90). 
 2-Nitroaminobenzene (52) (2.00 g, 14.5 mmol), 1,2-cyclohexanedione (89) (1.90 g, 16.9 
mmol), benzene (anhydrous, 40 mL) and concentrated H2SO4 (5 drops) were combined in a 
round-bottomed flask fitted with a Dean-Stark trap and a reflux condenser.  The reaction was 
heated and stirred at reflux for 21 h.  The reaction mixture was then concentrated.  Purification 
by flash chromatography (hexanes/EtOAc, 9:1, then 8:2) gave 90 (1.07 g, 4.6 mmol, 32%) as an 
orange solid:  mp 75-77 °C;  1H NMR δ 9.38 (br s, 1 H), 8.18 (dd, J = 8.7 and 1.5 Hz, 1 H), 7.43 
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(ddd, J = 8.7, 7.4 and 1.7 Hz, 1 H), 7.31 (dd, J = 8.7 and 1.5 Hz, 1 H), 6.87-6.77 (m, 2 H), 2.65-
2.54 (m, 4 H), 2.10 (pentet, J = 6.2 Hz, 2H);  13C NMR δ 194.6 (+), 140.6 (+), 135.2 (-), 134.8 
(+), 134.6 (+), 129.7 (-), 126.7 (-), 118.1 (-), 116.8 (-), 37.7 (+), 25.0 (+), 22.4 (+);  IR (neat) 
3294, 2944, 1672, 1571, 1430, 1246, 1155 cm-1. 
 
3-(2-Nitrophenylamino)-2-cyclohexen-1-one66 (92). 
 The same procedure as described for 90 was repeated except that a mixture of 2-
nitroaminobenzene (52) (1.26 g, 9.1 mmol), 1,3-cyclohexanedione (91) (1.00 g, 8.9 mmol), 
benzene (anhydrous, 30 mL) and concentrated H2SO4 (3 drops) was reacted for 22 h.  The 
product was recrystallized from EtOAc to give 92 (1.45 g, 6.3 mmol, 70%) as a yellow solid:  1H 
NMR (600 MHz) δ 8.66 (br s, 1 H), 8.17 (dd, J = 8.4 and 1.8 Hz, 1 H), 7.68 (dd, J = 7.8 and 1.2 
Hz, 1 H), 7.58 (dt, J = 7.2 and 1.8 Hz, 1 H), 7.15 (dt, J = 7.2 and 1.2 Hz, 1 H), 5.97 (s, 1 H), 2.60 
(t, J = 6.0 Hz, 2 H), 2.43 (t, J = 6.0 Hz, 2 H), 2.10 (pentet, J = 6.6 Hz, 2 H);  13C NMR (150 
MHz) δ 198.7, 158.0, 138.7, 135.7, 135.0, 126.4, 123.4, 123.1, 105.0, 36.6, 30.6, 21.5. 
 
(Z)-4-(2-Nitrophenylamino)-3-buten-2-one67 (95). 
 2-Nitroaminobenzene (52) (1.50 g, 10.9 mmol), (E)-4-methoxy-3-buten-2-one26 (94) (1.0 
mL, 9.8 mmol), p-toluenesulfonic acid (10 mg) and CH2Cl2 (anhydrous, 10 mL) were combined, 
heated and stirred at reflux for 9 h.  The reaction mixture was then concentrated.  Purification by 
flash chromatography (hexanes/EtOAc, 9:1) gave 95 (1.98 g, 9.6 mmol, 98%) as a yellow solid:  
1H NMR δ 13.11 (br s, 1 H), 8.24 (dd, J = 8.4 and 1.5 Hz, 1 H), 7.59 (t, J = 7.2 Hz, 1 H), 7.36 (d, 
J = 8.7 Hz, 1 H), 7.24 (dd, J = 11.8 and 8.1 Hz, 1 H), 7.08 (t, J = 8.4 Hz, 1 H), 5.55 (d, J = 8.1 
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Hz, 1 H), 2.24 (s, 3 H);  13C NMR (150 MHz) δ 199.0, 138.6, 137.4, 136.0, 135.5, 126.8, 121.5, 
115.4, 102.4, 30.0. 
 
(Z)-4-(4-Methyl-2-nitrophenylamino)-3-buten-2-one (96). 
 The same procedure as described for 95 was repeated except that a mixture of 4-methyl-
2-nitroaminobenzene (59) (2.00 g, 13.1 mmol), (E)-4-methoxy-3-buten-2-one26 (94) (1.4 mL, 
13.7 mmol), p-toluenesulfonic acid (10 mg) and CH2Cl2 (anhydrous, 15 mL) reacted at reflux for 
7 h.  The product was recrystallized from ethanol to give 96 (2.48 g, 11.2 mmol, 86%) as a 
yellow solid:  mp 135-137 °C;  1H NMR δ 13.00 (br s, 1 H), 8.04 (s, 1 H), 7.41 (d, J = 8.6 Hz, 1 
H), 7.25-7.15 (m, 2 H), 5.52 (d, J = 7.9 Hz, 1 H), 2.37 (s, 3 H), 2.23 (s, 3 H);  13C NMR δ 198.8 
(+), 139.1 (-), 136.5 (-), 135.7 (+), 135.1 (+), 131.8 (+), 126.3 (-), 115.4 (-), 101.7 (-), 29.9 (-), 
20.2  (-);  IR (neat) 1646, 1564, 1528, 1460, 1345, 1269, 1196 cm-1. 
 
 (Z)-4-(5-Methyl-2-nitrophenylamino)-3-buten-2-one (97). 
 The same procedure as described for 95 was repeated except that a mixture of 5-methyl-
2-nitroaminobenzene (93) (2.00 g, 13.1 mmol), (E)-4-methoxy-3-buten-2-one26 (94) (1.4 mL, 
13.7 mmol), p-toluenesulfonic acid (10 mg) and CH2Cl2 (anhydrous, 15 mL) reacted at reflux for 
12 h.  The product was recrystallized from ethanol to give 97 (2.07 g, 9.4 mmol, 71%) as an 
orange solid:  mp 124-126 °C;  1H NMR δ 13.10 (d, J = 9.9 Hz, 1 H), 8.14 (d, J = 8.6 Hz, 1 H), 
7.25 (dd, J = 11.9 and 8.3 Hz, 1 H), 7.14 (s, 1 H), 6.87 (d, J = 8.6 Hz, 1 H), 5.54 (d, J = 7.9 Hz, 1 
H), 2.43 (s, 3 H), 2.24 (s, 3 H);  13C NMR (150 MHz) δ 198.8 (+), 147.2 (+), 138.6 (-), 137.2 (+), 
133.7 (+), 126.6 (-), 122.6 (-), 115.3 (-), 102.1 (-), 29.9 (-), 21.9 (-);  IR (neat) 1654, 1595, 1500, 
1334, 1195, 1168 cm-1. 
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1,2-Dihydro-2,2,7-trimethylquinoxaline (98) and 3,4-dihydro-3,3,6-trimethyl-2-
quinoxalinone63 (99). 
 The same procedure as described for 57 was repeated except that a mixture of 4-methyl-
2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (60) (102 mg, 0.49 mmol), Pd(dba)2 (18 mg, 
0.031 mmol), dppp (14 mg, 0.034 mmol), 1,10-phenanthroline monohydrate (phen) (12 mg, 
0.067 mmol) and DMF (5 mL) was reacted at 70 °C under CO (6 atm) for 2 h.  The reaction 
mixture was diluted with CH2Cl2 (40 mL) and washed with brine (3 X 30 mL).  The combined 
aqueous phases were extracted with CH2Cl2 (1 X 30 mL).  The combined organic phases were 
dried (MgSO4), filtered and concentrated.  Purification by flash chromatography 
(hexanes/EtOAc, 7:3) gave 98 (43 mg, 0.25 mmol, 50%) and 99 (42 mg, 0.22 mmol, 45%) as 
off-white solids:  98 mp 112-115°C;  1H NMR δ 7.23 (s, 1 H), 7.13 (d, J = 7.7 Hz, 1 H), 6.53 (d, 
J = 7.7 Hz, 1 H), 6.31 (s, 1 H), 3.87 (d, J = 4.2 Hz, 1 H), 2.42 (s, 3 H), 1.30 (s, 6 H);  13C NMR δ 
159.5 (-), 139.0 (+), 136.4 (+), 129.2 (+), 127.4 (-), 119.2 (-), 114.1 (-), 50.3 (+), 27.1 (-), 21.4   
(-);  IR (neat) 3240, 2964, 1610, 1482, 1453, 1322, 1246 cm-1;  HRMS (EI) calc. for C11H14N2 
174.1157, found 174.1163;  99 1H NMR δ 8.46 (br s, 1 H), 6.64 (d, J = 7.9 Hz, 1 H), 6.57 (d, J = 
8.6 Hz, 1 H), 6.49 (s, 1 H), 3.87 (br s, 1 H), 2.24 (s, 3 H), 1.40 (s, 6 H);  13C NMR (150 MHz) δ 
171.5, 133.4, 132.7, 123.2, 119.9, 115.0, 114.9, 55.4, 25.5, 21.0. 
 
1,2-Dihydro-2,2-dimethyl-7-methoxyquinoxaline (100) and 3,4-dihydro-3,3-dimethyl-6-
methoxy-2-quinoxalinone68 (101).   
 The same procedure as described for 57 was repeated except that a mixture of 4-
methoxy-2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (62) (200 mg, 0.90 mmol), Pd(dba)2 
(31 mg, 0.05 mmol), dppp (22 mg, 0.05 mmol), phen (19 mg, 0.10 mmol) and DMF (3 mL) was 
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reacted at 70 °C under CO (6 atm) for 18 h.  The reaction mixture was diluted with CH2Cl2 (40 
mL) and washed with brine (3 X 40 mL).  The combined aqueous phases were extracted with 
CH2Cl2 (1 X 40 mL).  The combined organic phases were dried (MgSO4), filtered and 
concentrated.  Purification by flash chromatography (hexanes/EtOAc, 8:2 and 6:4) gave 100 (130 
mg, 0.68 mmol, 76%) and 101 (20 mg, 0.10 mmol, 11%) as off-white solids:  100 mp 65-66°C;  
1H NMR δ 7.20-7.10 (m, 2 H), 6.26 (dd, J = 8.6 and 2.5 Hz, 1 H), 6.02 (d, J = 2.5 Hz, 1 H), 3.85 
(s, 1 H), 3.74 (s, 3 H), 1.30 (s, 6 H);  13C NMR δ 160.1 (+), 157.7 (-), 137.8 (+), 128.6  (-), 125.7 
(+), 103.4 (-), 98.9 (-), 55.2 (-), 50.1 (+), 27.1 (-);  IR (neat) 3362, 3260, 2963, 1619, 1583, 1454, 
1249, 1209, 1166, 1035 cm-1;  HRMS (EI) calc. for C11H14N2O 190.1106, found 190.1103;  101 
1H NMR δ 7.81 (br s, 1 H), 6.62 (d, J = 8.4 Hz, 1 H), 6.32 (dd, J = 8.4 and 2.5 Hz, 1 H), 6.26 (d, 
J = 2.5 Hz, 1 H), 3.75 (s, 3 H), 3.67 (br s, 1 H), 1.41 (s, 6 H);  13C NMR (150 MHz) δ 170.6, 
156.5, 134.0, 119.4, 115.4, 104.1, 100.8, 55.5, 55.4, 25.5. 
 
7-Chloro-1,2-dihydro-2,2-dimethylquinoxaline (102) and 6-chloro-3,4-dihydro-3,3-
dimethyl-2-quinoxalinone68 (103). 
 The same procedure as described for 57 was repeated except that a mixture of 4-chloro-2-
nitro-N-[(2-methyl)-1-propenyl]benzenamine (64) (100 mg, 0.44 mmol), Pd(dba)2 (17 mg, 0.029 
mmol), dppp (12 mg, 0.029 mmol), phen (12 mg, 0.067 mmol) and DMF (5 mL) was reacted at 
70 °C under CO (6 atm) for 2 h.  The reaction mixture was diluted with CH2Cl2 (30 mL) and 
washed with brine (3 X 30 mL).  The combined aqueous phases were extracted with CH2Cl2 (1 X 
40 mL).  The combined organic phases were dried (MgSO4), filtered and concentrated.  
Purification by flash chromatography (hexanes/EtOAc, 7:3) gave 102 (48 mg, 0.25 mmol, 56%) 
and 103 (15 mg, 0.070 mmol, 16%) as off-white solids:  102 mp 136-138°C;  1H NMR δ 7.26 (s, 
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1 H), 7.14 (d, J = 8.2 Hz, 1 H), 6.67 (dd, J = 8.4 and 2.2 Hz, 1 H), 6.48 (d, J = 2.2 Hz, 1 H), 3.75 
(s, 1 H), 1.33 (s, 6 H);  13C NMR δ 160.3 (-), 137.6 (+), 133.8 (+), 129.9 (+), 128.7 (-), 118.2 (-), 
113.3 (-), 50.3 (-), 27.2 (-);  IR (neat) 3229, 2972, 1600, 1480, 1451, 1238 cm-1;  HRMS (EI) 
calc. for C10H11ClN2 194.0611, found 194.0611;  103 1H NMR δ 7.48 (br s, 1 H), 6.73 (dd, J = 
8.4 and 2.2 Hz, 1 H), 6.67 (d, J = 2.2 Hz, 1 H), 6.60 (d, J = 8.2 Hz, 1 H), 3.76 (br s, 1 H), 1.41 (s, 
6 H);  13C NMR (150 MHz) δ 170.9, 133.9, 128.6, 124.2, 119.1, 115.8, 114.1, 55.5, 25.6. 
 
6-Chloro-1,2-dihydro-2,2-dimethylquinoxaline (104) and 7-chloro-3,4-dihydro-3,3-
dimethyl-2-quinoxalinone68 (105). 
 The same procedure as described for 57 was repeated except that a mixture of 5-chloro-2-
nitro-N-[(2-methyl)-1-propenyl]benzenamine (66) (200 mg, 0.88 mmol), Pd(dba)2 (30 mg, 0.052 
mmol), dppp (23 mg, 0.056 mmol), phen (21 mg, 0.117 mmol) and DMF (10 mL) was reacted at 
70 °C under CO (6 atm) for 5.5 h.  The reaction mixture was diluted with CH2Cl2 (20 mL) and 
washed with brine (3 X 30 mL).  The combined aqueous phases were extracted with CH2Cl2 (1 X 
40 mL).  The combined organic phases were dried (MgSO4), filtered and concentrated.  
Purification by flash chromatography (hexanes/EtOAc, 8:2) gave 104 (50 mg, 0.26 mmol, 29%) 
and 105 (84 mg, 0.40 mmol, 45%) as off-white solids:  104 mp 112-114°C;  1H NMR δ 7.29 (d, 
J = 1.7 Hz, 1 H), 7.23 (d, J = 2.5 Hz, 1 H), 6.96 (dd, J = 8.4 and 2.2 Hz, 1 H), 6.42 (d, J = 8.4 
Hz, 1 H), 3.78 (br s, 1 H), 1.31 (s, 6 H);  13C NMR δ 161.5 (-), 135.3 (+), 132.1 (+), 128.4 (-), 
127.3 (-), 122.5 (+), 114.5 (-), 50.4 (+), 27.0 (-);  IR (neat) 3249, 2970, 1600, 1485, 1455 cm-1;  
HRMS (EI) calc. for C10H11ClN2 194.0611, found 194.0619;  105 1H NMR δ 8.59 (br s, 1 H), 
6.85 (dd, J = 8.4 and 2.2 Hz, 1 H), 6.76 (d, J = 2.0 Hz, 1 H), 6.59 (d, J = 8.4 Hz, 1 H), 3.72 (br s, 
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1 H), 1.41 (s, 6 H);  13C NMR (150 MHz) δ 171.3, 131.5, 126.6, 124.1, 123.4, 115.1, 115.0, 55.5, 
25.5. 
 
1,2-Dihydro-2,2,5-trimethylquinoxaline (106) and 3,4-dihydro-3,3,8-trimethyl-2-
quinoxalinone68 (107). 
 The same procedure as described for 57 was repeated except that a mixture of 6-methyl-
2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (68) (43 mg, 0.21 mmol), Pd(dba)2 (7 mg, 0.012 
mmol), dppp (7 mg, 0.017 mmol), phen (7 mg, 0.039 mmol) and DMF (5 mL) was reacted at 70 
°C under CO (6 atm) for 2 h.  The reaction mixture was diluted with CH2Cl2 (30 mL) and 
washed with brine (3 X 30 mL).  The combined aqueous phases were extracted with CH2Cl2 (1 X 
30 mL).  The combined organic phases were dried (MgSO4), filtered and concentrated.  
Purification by flash chromatography (hexanes/EtOAc, 8:2) gave 106 (10 mg, 0.057 mmol, 27%) 
and 107 (17 mg, 0.089 mmol, 42%) as off-white solids:  106 mp 79-81°C;  1H NMR δ 7.29 (s, 1 
H), 6.91 (t, J = 7.7 Hz, 1 H), 6.58 (d, J = 7.7 Hz, 1 H), 6.35 (d, J = 7.7 Hz, 1 H), 3.65 (br s, 1 H), 
2.41 (s, 3 H), 1.31 (s, 6 H);  13C NMR (150 MHz) δ 158.8 (-), 136.5 (+), 135.6 (+), 129.8 (+), 
128.1 (-), 119.9 (-), 111.6 (-), 49.5 (+), 26.7 (-), 17.2 (-);  IR (neat) 3275, 2960, 1590, 1464, 
1289, 1160 cm-1;  107 1H NMR δ 7.51 (br s, 1 H), 6.81 (t, J = 7.6 Hz, 1 H), 6.63 (d, J = 6.9 Hz, 1 
H), 6.55 (d, J = 7.9 Hz, 1 H), 3.68 (br s, 1 H), 2.22 (s, 3 H), 1.40 (s, 6 H);  13C NMR (150 MHz) 
δ 171.0, 132.7, 123.8, 123.2, 122.6, 121.2, 112.5, 55.3, 25.4, 16.4. 
 Alternate procedure for 2-methyl-6-nitroaminobenzene69 (67), 1,2-dihydro-2,2,5-
trimethylquinoxaline (106) and 2-isopropyl-4-methylbenzimidazole70 (136).  To a solution of 
2-azido-3-nitrotoluene (135) (1.00 g, 5.6 mmol) dissolved in diethyl ether (anhydrous, 40 mL) 
was added triphenylphosphine (1.5 g, 5.7 mmol).  The mixture stirred under argon atmosphere at 
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ambient temperature for 1 h.  The reaction was then concentrated.  To the resulting solid was 
added CHCl3 (40 mL) and 2-methylpropanal (55) (7.0 mL, 77.0 mmol).  The reaction mixture 
stirred at reflux under argon atmosphere for 6 days.  The red color of the reaction, as well as 
TLC, indicated that the desired enamine had been formed.  The reaction was concentrated and 
the crude solid was used without further purification. 
 To a solution of the crude enamine dissolved in DMF (8 mL) in a threaded pressure tube 
fitted with a pressure head was added Pd(dba)2 (190 mg, 0.3 mmol), dppp (140 mg, 0.3 mmol) 
and phen (120 mg, 0.7 mmol).  The tube was flushed 3 times with CO.  The reaction was heated 
and stirred at 70 °C under CO (6 atm) for 21 h.  The reaction mixture was concentrated and the 
product was purified by flash chromatography (hexanes/EtOAc, 9:1, 8:2, 1:1, 3:7 and EtOAc) to 
give 67 (71 mg, 0.47 mmol, 8%) as a yellow solid, 106 (106 mg, 0.6 mmol, 11%) as a pale 
yellow solid and 136 (603 mg, 3.46 mmol, 62%) as a tan solid. 
 
1,2-Dihydro-2,2,8-trimethylquinoxaline (108) and 3,4-dihydro-3,3,5-trimethyl-2-
quinoxalinone68 (109). 
 The same procedure as described for 57 was repeated except that a mixture of 3-methyl-
2-nitro-N-[(2-methyl)-1-propenyl]benzenamine (72) (228 mg, 1.1 mmol), Pd(dba)2 (38 mg, 
0.067 mmol), dppp (27 mg, 0.065 mmol), phen (24 mg, 0.13 mmol) and DMF (3 mL) was 
reacted at 70 °C under CO (6 atm) for 14 h.  The solvent was removed under high vacuum.  
Purification by flash chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3 and 1:1) gave 108 (120 mg, 
0.69 mmol, 63%) and 109 (26 mg, 0.14 mmol, 12%) as off-white solids:  108 mp 95-97°C;  1H 
NMR δ 7.28 (d, J = 2.0 Hz, 1 H), 7.14 (d, J = 7.9 Hz, 1 H), 6.93 (d, J = 7.4 Hz, 1 H), 6.65 (t, J = 
7.7 Hz, 1 H), 3.53 (br s, 1 H), 2.10 (s, 3 H), 1.34 (s, 6 H);  13C NMR δ 159.7 (-), 134.5 (+), 130.7 
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(+), 129.8 (-), 125.5 (-), 120.8 (+), 117.3 (-), 50.2 (+), 27.3 (-), 16.0 (-);  IR (neat) 2964, 1624, 
1600, 1497, 1280, 1082 cm-1;  109 mp 182-184 °C;  1H NMR δ 8.82 (br s, 1 H), 6.79 (dd, J = 6.7 
and 2.0 Hz, 1 H), 6.73-6.63 (m, 2 H), 3.58 (br s, 1 H), 2.17 (s, 3 H), 1.43 (s, 6 H);  13C NMR 
(150 MHz) δ 171.4, 130.9, 125.2, 125.1, 122.1, 118.8, 113.2, 55.4, 25.8, 16.6. 
 
(3,4-Dihydro-3,3-dimethylquinoxalin-6-yl)phenylmethanone (110). 
 The same procedure as described for 57 was repeated except that a mixture of [4-(2-
methylpropenylamino)-3-nitrophenyl]phenylmethanone (74) (120 mg, 0.40 mmol), Pd(dba)2 (14 
mg, 0.024 mmol), dppp (10 mg, 0.024 mmol), phen (9 mg, 0.048 mmol) and DMF (5 mL) was 
reacted at 70 °C under CO (6 atm) for 18 h.  The reaction mixture was filtered through Celite 
with EtOAc and the filtrate was concentrated.  After numerous attempts to purify the product by 
flash chromatography, the yellow solid that was isolated was tentatively determined to be 110 
(<56 mg, <0.2 mmol, <52%):  1H NMR δ 7.79 (dd, J = 8.4 and 1.5 Hz, 2 H), 7.57 (t, J = 7.4 Hz, 
1 H), 7.46 (t, J = 7.6 Hz, 2 H), 7.39 (d, J = 1.7 Hz, 1 H), 7.30 (d, J = 7.9 Hz, 1 H), 7.08 (dd, J = 
7.9 and 1.8 Hz, 1 H), 7.03 (d, J = 1.7 Hz, 1 H), 4.08 (br s, 1 H), 1.34 (s, 6 H);  13C NMR δ 196.4 
(+), 163.0 (-), 137.6 (+), 137.5 (+), 136.8 (+), 134.3 (+), 132.2 (-), 129.9 (-), 128.1 (-), 127.1 (-), 
120.8 (-), 115.0 (-), 50.5 (+), 27.1 (-). 
 
Methyl 3,4-dihydro-3,3-dimethylquinoxaline-6-carboxylate (111) and methyl 1,2,3,4-
tetrahydro-3,3-dimethyl-2-oxoquinoxaline-6-carboxylate (112). 
 The same procedure as described for 57 was repeated except that a mixture of methyl 4-
(2-methylpropenylamino)-3-nitrobenzoate (76) (250 mg, 1.0 mmol), Pd(dba)2 (35 mg, 0.061 
mmol), dppp (25 mg, 0.061 mmol), phen (22 mg, 0.12 mmol) and DMF (5 mL) was reacted at 70 
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°C under CO (6 atm) for 17 h.  The reaction mixture was then concentrated.  Purification by flash 
chromatography (hexanes/EtOAc, 8:2 and 6:4) gave an inseparable mixture of 111 (6 mg, 0.03 
mmol, 3%) and 112 (5 mg, 0.02 mmol, 2%) as a tan solid71:  data for the mixture 1H NMR δ 8.93 
(s, 1 H), 8.53 (s, 1 H), 7.97 (d, J = 8.2 Hz, 1 H), 7.56 (dd, J = 8.2 and 1.5 Hz, 1 H), 7.49 (dd, J = 
8.2 and 1.5 Hz, 1 H), 7.29 (d, J = 1.2 Hz, 1 H), 6.98 (d, J = 8.2 Hz, 1 H), 4.08 (br s, 1 H), 3.94 
(br s, 1 H), 3.88 (s, 6 H), 1.81 (s, 6 H), 1.71 (s, 6 H) (Note: One proton signal is missing.  It is 
most likely masked by the solvent residual peak at 7.27 ppm). 
 
7’-Methoxy-spiro[cyclohexane-1,2’(1’H)quinoxaline] (113) and 1’,4’-dihydro-7’-methoxy-
spiro[cyclohexane-1,2’(3’H)quinoxalin]3’-one (114). 
 The same procedure as described for 57 was repeated except that a mixture of 4-
methoxy-2-nitro-N-(cyclohexylmethylene)benzenamine (78) (201 mg, 0.77 mmol), Pd(dba)2 (27 
mg, 0.047 mmol), dppp (19 mg, 0.046 mmol), phen (19 mg, 0.105 mmol) and DMF (10 mL) was 
reacted at 70 °C under CO (6 atm) for 4.5 h.  The reaction mixture was diluted with CH2Cl2 (40 
mL) and washed with brine (4 X 50 mL).  The combined aqueous phases were extracted with 
CH2Cl2 (1 X 50 mL).  The combined organic phases were dried (MgSO4), filtered and 
concentrated.  Purification by flash chromatography (hexanes/EtOAc, 7:3) gave 113 (123 mg, 
0.534 mmol, 70%) and 114 (24 mg, 0.097 mmol, 13%) as off-white solids:  113 mp 141-142°C;  
1H NMR δ 7.23 (s, 1 H), 7.15 (d, J = 8.4 Hz, 1 H), 6.27 (dd, J = 8.4 and 2.5 Hz, 1 H), 6.08 (d, J 
= 2.7 Hz, 1 H), 4.06 (br s, 1 H), 3.76 (s, 3 H), 1.80-1.30 (m, 10 H);  13C NMR δ 160.0 (+), 157.7 
(-), 137.7 (+), 128.5 (-), 126.5 (+), 103.4 (-), 99.0 (-), 55.1 (-), 51.4 (+), 34.7 (+), 25.1 (+), 20.3 
(+);  IR (neat) 3243, 2927, 1612, 1582, 1466, 1308, 1257, 1102 cm-1;  HRMS (EI) calc. for 
C14H18N2O 230.1419, found 230.1410;  114 mp 260-263°C;  1H NMR (DMSO-d6) δ 9.93 (s, 
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1H), 6.59 (d, J = 8.4 Hz, 1 H), 6.52 (d, J = 2.5 Hz, 1 H), 6.17 (dd, J = 8.6 and 2.5 Hz, 1 H), 5.96 
(s, 1 H), 3.63 (s, 3 H), 1.7- 1.4 (m, 10 H);  13C NMR (DMSO-d6) δ 169.5 (+), 155.3 (+), 134.4 
(+), 120.0 (+), 116.6 (-), 102.8 (-), 100.3 (-), 55.6 (+), 54.9 (-), 31.4 (+), 25.0 (+), 19.9 (+);  IR 
(neat) 3368, 2929, 1672, 1518, 1259, 1015 cm-1;  HRMS (EI) calc for C14H18N2O2 246.1368, 
found 246.1371. 
 
1,2-Dihydro-2,2-diphenyl-7-methoxyquinoxaline (115). 
 The same procedure as described for 57 was repeated except that a mixture of 4-
methoxy-2-nitro-N-(2,2-diphenylethenyl)benzenamine (80) (96 mg, 0.28 mmol), Pd(dba)2 (10 
mg, 0.017 mmol), dppp (7 mg, 0.017 mmol), phen (7 mg, 0.039 mmol) and DMF (4 mL) was 
reacted at 70 °C under CO (6 atm) for 18 h.  The solvent was removed under high vacuum.  
Purification by flash chromatography (hexanes/EtOAc, 8:2) gave 115 (60 mg, 0.19 mmol, 69%) 
as a tan solid:  mp 164-166°C;  1H NMR δ 7.59 (d, J = 2.5 Hz, 1 H), 7.40-7.25 (m, 10 H), 7.19 
(d, J = 8.7 Hz, 1 H), 6.27 (dd, J = 8.4 and 2.5 Hz, 1 H), 6.09 (d, J = 2.5 Hz, 1 H), 4.43 (br s, 1 H), 
3.75 (s, 3 H);  13C NMR δ 160.5 (+), 153.3 (-), 144.1 (+), 136.5 (+), 129.1 (-), 128.6 (-), 127.6   
(-), 127.4 (-), 124.7 (+), 103.8 (-), 98.4 (-), 62.5 (+), 55.2 (-);  IR (neat) 3232, 2998, 2930, 1594, 
1486, 1293, 1224, 1174, 1033 cm-1;  HRMS (EI) calc. for C21H18N2O 314.1419, found 314.1409. 
 
7-Chloro-2-phenylquinoxaline19 (116) and 6-chloro-3-phenyl-2-quinoxalinol72 (117). 
 The same procedure as described for 57 was repeated except that a mixture of (E) and 
(Z)-4-chloro-2-nitro-N-(2-phenylethylene)benzenamine (82) (106 mg, 0.39 mmol), Pd(dba)2 (13 
mg, 0.023 mmol), dppp (10 mg, 0.024 mmol), phen (10 mg, 0.055 mmol) and DMF (10 mL) was 
reacted at 70 °C under CO (6 atm) for 48 h.  The reaction mixture was diluted with CH2Cl2 (20 
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mL) and washed with brine (3 X 30 mL).  The combined aqueous phases were extracted with 
CH2Cl2 (1 X 30 mL).  The combined organic phases were dried (MgSO4), filtered and 
concentrated.  Purification by flash chromatography (hexanes/EtOAc, 9:1) gave 116 (23 mg, 
0.096 mmol, 25%) and 117 (14 mg, 0.055 mmol, 14%) as off-white solids:  116 1H NMR δ 8.91 
(s, 1 H), 8.69 (d, J = 2.2 Hz, 1 H), 8.08 (d, J = 8.9 Hz, 1 H), 8.00-7.95 (m, 2 H), 7.76 (dd, J = 8.9 
and 2.2 Hz, 1 H), 7.62-7.51 (m, 3 H);  13C NMR (150 MHz) δ 147.5 (-). 143.0 (+), 139.8, 137.8, 
137.0 (+), 132.2 (-), 131.4 (-), 130.6 (-), 129.5 (+), 129.4 (-), 128.8 (-), 119.0 (-);  117 1H NMR δ 
9.32 (s, 1 H), 8.22-8.18 (m, 2 H), 8.16 (d, J = 2.2 Hz, 1 H), 8.06 (d, J = 8.9 Hz, 1 H), 7.69 (dd, J 
= 8.9 and 2.2 Hz, 1 H), 7.60-7.56 (m, 3 H);  13C NMR (150 MHz) δ 152.6, 143.4, 142.7, 140.1, 
136.3, 136.1, 130.6, 130.5, 130.4, 129.2, 128.5, 127.6. 
 
1,2-Dihydro-2,2-dimethylpyrido[2,3-b]pyrazine (118) and 1,2-dihydro-2,2-
dimethylpyrido[2,3-b]pyrazin-3-one (119). 
 The same procedure as described for 57 was repeated except that a mixture of 3-nitro-N-
[(2-methyl)-1-propenyl]-2-pyridinamine (87) (100 mg, 0.52 mmol), Pd(dba)2 (18 mg, 0.031 
mmol), dppp (14 mg, 0.034 mmol), phen (13 mg, 0.072 mmol) and DMF (5 mL) was reacted at 
70 °C under CO (6 atm) for 6 h.  The reaction mixture was diluted with EtOAc (30 mL) and 
washed with brine (3 X 30 mL).  The combined aqueous phases were extracted with EtOAc (1 X 
30 mL).  The combined organic phases were dried (MgSO4), filtered and concentrated.  
Purification by flash chromatography (hexanes/EtOAc, 7:3) gave 118 (28 mg, 0.17 mmol, 34%) 
and 119 (5 mg, 0.028 mmol, 6%) as off-white solids:  118 1H NMR δ 9.28 (s, 1 H), 7.57 (dd, J = 
4.7 and 1.5 Hz, 1 H), 6.85-6.70 (m, 2 H), 4.03 (br s, 1 H), 1.81 (s, 6 H);  13C NMR δ 157.5 (-), 
146.2 (+), 137.5 (-), 131.9 (+), 119.6 (-), 115.2 (-), 80.0 (+), 27.5 (-);  IR (neat) 2976, 1674, 
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1609, 1444, 1343, 1245 cm-1;  119 mp  202-205°C;  1H NMR δ 9.24 (br s, 1 H), 7.83 (dd, J = 4.9 
and 1.5 Hz, 1 H), 6.94 (dd, J = 7.9 and 1.5 Hz, 1H), 6.84 (dd, J = 7.7 and 4.9 Hz, 1 H), 3.72 (br s, 
1 H), 1.45 (s, 6 h);  13C NMR δ 171.0 (+), 140.3 (+), 137.9 (-), 128.5 (+), 120.2 (-), 119.1 (-), 
56.0 (+), 26.1(-);  IR (neat) 3310, 1683, 1558, 1458, 1289  cm-1;  HRMS (EI) calc. for C9H11N3O 
177.0902, found 177.0899. 
 
1-Hydroxyphenazine69 (120), 1,2,3,4-tetrahydrophenazine73 (121) and 3,4-dihydrophenazin-
1(2H)-one74 (122). 
 The same procedure as described for 57 was repeated except that a mixture of 2-(2-
nitrophenylamino)-2-cyclohexen-1-one (90) (100 mg, 0.4 mmol), Pd(dba)2 (15 mg, 0.026 mmol), 
dppp (11 mg, 0.027 mmol), phen (10 mg, 0.061 mmol) and DMF (2 mL) was reacted at 70 °C 
under CO (6 atm) for 22 h.  The solvent was removed under high vacuum.  Purification by flash 
chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1 and 3:7) gave 120 (5 mg, 0.025 mmol, 6%), 
121 (6 mg, 0.033 mmol, 8%) and 122 (13 mg, 0.066 mmol, 15%) as brown solids:  122 1H NMR 
δ 8.33 (dd, J = 8.4 and 1.5 Hz, 1 H), 8.07 (dd, J = 8.2 and 1.5 Hz, 1 H), 7.88 (dt, J = 6.9 and 1.5 
Hz, 1 H), 7.81 (dt, J = 6.9 and 1.5 Hz, 1 H), 3.43 (t, J = 6.2 Hz, 2 H), 3.01 (t, J = 6.2 Hz, 2 H), 
2.37 (pentet, J = 6.4 Hz, 2 H). 
 Alternate procedure A for 120.  Compound 122 (25 mg, 0.13 mmol), 10% Pd/C (20 
mg, 0.02 mmol Pd), 1,2,4-trimethylbenzene (0.15 mL, 1.1 mmol) and diphenyl ether (1.0 mL) 
were combined in a threaded pressure tube fitted with a Teflon cap.  The reaction was heated and 
stirred at 230 °C for 20 h.  The mixture was then filtered through silica gel and washed with 
EtOAc.  The filtrate was then concentrated.  The remaining diphenyl ether was removed by bulb-
to-bulb distillation to give 120 (5 mg, 0.025 mmol, 20%) as a brown solid. 
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 Alternate procedure B for 120.  The same procedure as described for 57 was repeated 
except that a mixture of 3-(2-nitrophenylamino)-2-cyclohexen-1-one (92) (302 mg, 1.3 mmol), 
Pd(dba)2 (45 mg, 0.08 mmol), dppp (33 mg, 0.08 mmol), phen (30 mg, 0.17 mmol) and DMF (4 
mL) was reacted at 120 °C under CO (6 atm) for 22 h.  The mixture was then filtered through 
Celite and the filtrate was concentrated under high vacuum.  Purification by flash 
chromatography (hexanes/EtOAc, 8:2, 7:3, 1:1 and EtOAc) gave 120 (67 mg, 0.34 mmol, 26%) 
as a brown solid. 
 
2-Acetylquinoxaline (123). 
 The same procedure as described for 57 was repeated except that a mixture of (Z)-4-(2-
nitrophenylamino)-3-buten-2-one (95) (200 mg, 1.0 mmol), Pd(dba)2 (33 mg, 0.06 mmol), dppp 
(24 mg, 0.06 mmol), phen (23 mg, 0.13 mmol) and DMF (10 mL) was reacted at 90 °C under 
CO (6 atm) for 44 h.  The mixture was diluted with CH2Cl2 (30 mL) and washed with H2O (3 X 
30 mL).  The combined aqueous phases were extracted with CH2Cl2 (30 mL).  The combined 
organic phases were dried (MgSO4), filtered and concentrated.  Purification by flash 
chromatography (hexanes/EtOAc, 8:2, 7:3, 1:1) gave 123 (10 mg, 0.06 mmol, 6%) as a brown 
solid:  1H NMR δ 9.51 (s, 1 H), 8.23-8.17 (m, 2 H), 7.94-7.84 (m, 2 H), 2.87 (s, 3 H);  13C NMR 
(150 MHz) δ 199.8, 146.6, 143.9, 143.1 (-), 141.1, 132.2 (-), 130.7 (-), 130.5 (-), 129.4 (-), 25.5. 
 
2-Acetyl-6-methylquinoxaline (124) and 2-acetyl-7-methylquinoxaline (125). 
 The same procedure as described for 57 was repeated except that a mixture of (Z)-4-(4-
methyl-2-nitrophenylamino)-3-buten-2-one (96) (100 mg, 0.45 mmol), Pd(dba)2 (16 mg, 0.03 
mmol), dppp (11 mg, 0.03 mmol), phen (10 mg, 0.06 mmol) and DMF (2 mL) was reacted at 70 
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°C under CO (6 atm) for 21 h.  The solvents were removed under reduced pressure.  Purification 
by flash chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1, 3:7 and EtOAc) gave an inseparable 
mixture of 124 and 125 (11 mg, 0.06 mmol, 13%) as a pale yellow solid:  data for the mixture 1H 
NMR δ 9.46 (s, 1 H), 9.43 (s, 1 H), 8.08 (d, J = 8.6 Hz, 1 H), 8.06 (d, J = 8.7 Hz, 1 H), 7.98 (s, 1 
H), 7.94 (s, 1 H), 7.71 (apparent dt, J = 9.1 and 2.0 Hz, 2 H), 2.85 (s, 6 H), 2.65 (s, 6 H);  13C 
NMR (150 MHz) δ 199.9, 199.8, 146.6, 146.0, 144.0, 143.1, 142.4, 142.2, 141.4, 141.2, 139.5, 
134.6, 133.1, 130.0, 129.2, 128.9, 128.4, 128.3, 25.5, 25.5, 22.1, 21.8. 
 Alternate procedure A for 124 and 125.  The same procedure as described for 57 was 
repeated except that a mixture of (Z)-4-(5-methyl-2-nitrophenylamino)-3-buten-2-one (97) (500 
mg, 2.3 mmol), Pd(dba)2 (78 mg, 0.14 mmol), dppp (56 mg, 0.14 mmol), phen (49 mg, 0.27 
mmol) and DMF (2 mL) was reacted at 70 °C under CO (6 atm) for 20 h.  The solvents were 
removed under reduced pressure.  Purification by flash chromatography (hexanes/EtOAc, 9:1, 
8:2, 7:3, 1:1, 3:7 and EtOAc) gave an inseparable mixture of 124 and 125 (15 mg, 0.08 mmol, 
4%) as a pale yellow solid. 
 Alternate procedure B for 124 and 125.  Compound 153 (205 mg, 0.95 mmol), p-
toluenesulfonic acid (10 mg) and ethanol (50 mL) were combined and heated to reflux for 27 h.  
The reaction mixture was then concentrated.  Purification by flash chromatography 
(hexanes/EtOAc, 9:1, 8:2, 7:3, 6:4 and 1:1) gave an inseparable mixture of 124 and 125 (11 mg, 
0.06 mmol, 6%) as a pale yellow solid. 
 
2-Azido-1-nitrobenzene75 (131). 
 To a solution of 2-nitroaminobenzene (52) (5.00 g, 36.2 mmol) dissolved in H2O (300 
mL) at 0 °C was added HCl (concentrated, 75 mL).  Small amounts of ice were added 
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periodically to keep the solution at 0 °C.  The solution of amine hydrochloride stirred for 5 
minutes.  NaNO2 (3.00 g, 43.5 mmol in 10 mL H2O) was added to the cold solution and the 
reaction stirred for 3 h.  The remaining insoluble solid was removed by filtration.  To the filtrate 
was added NaN3 (2.90 g, 44.6 mmol in 10 mL H2O).  Small amounts of diethyl ether were used 
to stop the foaming that resulted.  The solution was stirred for 2 h.  The resulting solid was 
removed by filtration and washed with cold diethyl ether to give 131 (4.75 g, 29.0 mmol, 80%) 
as an off-white solid:  1H NMR δ 7.95 (dd, J = 8.2 and 1.2 Hz, 1 H), 7.63 (dt, J = 7.8 and 1.5 Hz, 
1 H), 7.35 (dd, J = 8.2 and 1.0 Hz, 1 H), 7.27 (dt, J = 7.8 and 1.0 Hz, 1 H);  13C NMR (150 MHz) 
δ 140.8 (+), 134.7 (+), 134.0 (-), 126.0 (-), 124.9 (-), 120.7 (-). 
 
2-Pentylquinoxaline (132), 2-pentylquinoxaline-1-oxide (133) and 2-hexylbenzimidazole76 
(134). 
 To a solution of 2-azidonitrobenzene (131) (500 mg, 3.1 mmol) dissolved in diethyl ether 
(anhydrous, 20 mL) was added triphenylphosphine (800 mg, 3.1 mmol).  The mixture stirred 
under argon atmosphere at ambient temperature for 1 h.  The reaction was then concentrated.  To 
the resulting solid was added CHCl3 (25 mL) and heptanal (83) (4.0 mL, 29.8 mmol).  The 
reaction mixture stirred at reflux under argon atmosphere for 7 days.  The red color of the 
reaction, as well as TLC, indicated that the desired enamine had been formed.  The reaction was 
concentrated and the crude solid was used without further purification. 
 To a solution of the crude enamine dissolved in DMF (10 mL) in a threaded pressure tube 
fitted with a pressure head was added Pd(dba)2 (110 mg, 0.2 mmol), dppp (80 mg, 0.2 mmol) and 
phen (70 mg, 0.4 mmol).  The tube was flushed 3 times with CO.  The reaction was heated and 
stirred at 70 °C under CO (6 atm) for 72 h.  The reaction mixture was concentrated and the 
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product was purified by flash chromatography (hexanes/EtOAc, 8:2, 7:3, 6:4, 1:1 and 3:7) to 
give 132 (153 mg, 0.76 mmol, 25%) as a yellow oil, 133 (54 mg, 0.25 mmol, 8%) as an off-white 
solid and 134 (84 mg, 0.42 mmol, 14%) as a tan solid:  132 1H NMR δ 8.75 (s, 1 H), 8.06 
(apparent triplet with further fine splitting, J = 9.4 Hz, 2 H), 7.76 (dt, J = 6.7 and 1.7 Hz, 1H) 
partially overlapping 7.71 (dt, J = 6.9 and 1.7 Hz, 1 H), 3.02 (t, J = 7.7 Hz, 2 H), 1.86 (pentet, J 
= 7.6 Hz, 2 H), 1.47-1.32 (m, 4 H), 0.91 (t, J = 7.0 Hz, 3 H);  13C NMR (150 MHz) δ 157.6 (+), 
145.7 (-), 142.1 (+), 141.1 (+), 129.8 (-), 129.1 (-), 128.8 (-), 128.7 (-), 36.4 (+), 31.5 (+), 29.1 
(+), 22.4 (+), 13.9 (-);  IR (neat) 2957, 2927, 2857, 1561, 1492, 1126, 761 cm-1;  133 mp 32-34 
°C;  1H NMR δ 8.69 (s, 1 H), 8.61 (apparent doublet with further fine splitting, J = 10.1 Hz, 1 
H), 8.10 (apparent doublet with further fine splitting, J = 9.7 Hz, 1 H), 7.81-7.71 (m, 2 H), 3.08 
(t, J = 7.7 Hz, 2 H), 1.84 (pentet, J = 7.4 Hz, 2 H), 1.48-1.38 (m, 4 H), 0.93 (t, J = 6.9 Hz, 3 H);  
13C NMR (150 MHz) δ 146.8 (-), 144.4 (+), 143.0 (+), 137.0 (+), 130.5 (-), 130.0 (-), 129.9 (-), 
118.7 (-), 31.7 (+), 28.7 (+), 25.2 (+), 22.3 (+), 13.9 (-);  IR (neat) 2957, 2927, 2860, 1579, 1494, 
1359, 1302, 766 cm-1. 
 
2-Azido-3-nitrotoluene77 (135). 
 The same procedure as described for 131 was repeated except that a mixture of 2-methyl-
6-nitroaminobenzene (67) (3.00 g, 19.7 mmol), H2O (100 mL), HCl (concentrated, 100 mL), 
NaNO2 (1.70 g, 24.6 mmol) and NaN3 (2.50 g, 38.5 mmol) gave 135 (2.62 g, 14.7 mmol, 75%) as 
a pale yellow solid:  1H NMR δ 7.80 (d, J = 8.2 Hz, 1 H), 7.45 (d, J = 7.4 Hz, 1 H), 7.21 (t, J = 
7.9 Hz, 1 H), 2.43 (s, 3 H);  13C NMR (150 MHz) δ 143.8 (+), 135.5 (-), 135.3 (+), 132.1 (+), 
125.4 (-), 123.4 (-), 18.1 (-). 
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2-Azido-4-chloroaminobenzene78 (150). 
 To a solution of 185 (5.50 g, 18.2 mmol) dissolved in methanol (35 mL) was added 
hydrazine hydrate (85% aqueous solution, 1.1 mL).  The reaction proceeded at ambient 
temperature with occasional stirring for 30 minutes.  The resulting paste was added to an 
aqueous NaOH solution (0.25 M, 330 mL).  The insoluble solid was removed by filtration and 
added to ethanol (150 mL) with stirring.  The insoluble solid was removed by filtration and the 
filtrate was added to H2O (500 mL).  The resulting solid was removed by filtration to give 150 
(1.90 g, 11.3 mmol, 62%) as an off-white solid. 
 
5-Chloro-2-isopropylbenzimidazole79 (151). 
 To a refluxing solution of 2-azido-5-chloroaminobenzene (186) (300 mg, 1.8 mmol) 
dissolved in ethanol (absolute, 50 mL) was added dropwise a solution of 2-methylpropanal (55) 
(0.195 mL, 2.2 mmol) dissolved in ethanol (absolute, 20 mL).  The reaction was stirred at reflux 
for 24 h, then concentrated.  The crude solid was purified by column chromatography 
(hexanes/EtOAc, 8:2, 7:3, 1:1 and 3:7) to give 151 (262 mg, 1.4 mmol, 76%) as a brown solid:  
1H NMR δ 7.51 (d, J = 1.7 Hz, 1 H), 7.43 (d, J = 8.7 Hz, 1 H), 7.18 (dd, J = 8.7 and 2.0 Hz, 1 H), 
3.28 (septet, J = 6.9 Hz, 1 H), 1.46 (d, J = 6.9 Hz, 6 H);  13C NMR δ 161.2, 127.8, 122.7, 114.5 
(broad signal), 29.1, 21.5 (Note: three carbons were not observed due to the slow exchange of the 
N-H proton, which causes these signals to be broadened). 
 Alternate procedure A for compound 151.  Compound 151 was also prepared 
according to the method above except that a mixture of 2-azido-4-chloroaminobenzene (150) 
(174 mg, 1.0 mmol), ethanol (absolute, 70 mL total) and 2-methylpropanal (55) (0.115 mL, 1.3 
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mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1 and 3:7) gave 151 (132 
mg, 0.68 mmol, 66%) as a brown solid. 
 Alternate procedure B for compound 151.  2-azido-4-chloroaminobenzene (150) (405 
mg, 2.4 mmol), ethanol (absolute, 20 mL total) and 2-methylpropanal (55) (0.600 mL, 6.6 mmol) 
were reacted as described above with the following change:  Glacial acetic acid (0.5 mL) was 
added to the azide solution before heating to reflux.  After 24 h and chromatography 
(hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1 and 3:7), 151 (287 mg, 1.5 mmol, 61%) was isolated as a 
brown solid. 
 
2-Azido-4-methylaminobenzene78 (152). 
 To a solution of 194 (9.50 g, 34.1 mmol) dissolved in THF (200 mL) and ethanol (35 
mL) was added hydrazine hydrate (85% aqueous solution, 14 mL).  The reaction stirred at 
ambient temperature for 20 h.  The insoluble solid was removed by filtration and washed with 
cold ethanol.  The filtrate was added to H2O (0ºC, 700 mL) and extracted with diethyl ether (6 X 
150 mL).  The organic phase was dried (MgSO4), filtered and concentrated to give 152 (4.90 g, 
33.3 mmol, 98%) as an off-white solid. 
 
(Z)-4-(2-Azido-4-methylphenylamino)-3-buten-2-one (153). 
 The same procedure as described for 95 was repeated except that a mixture of 2-azido-4-
methylaminobenzene (152) (600 mg, 4.1 mmol), (E)-4-methoxy-3-buten-2-one26 (94) (0.5 mL, 
4.9 mmol), p-toluenesulfonic acid (10 mg) and CH2Cl2 (anhydrous, 25 mL) reacted at ambient 
temperature for 72 h.  Purification by flash chromatography (hexanes/EtOAc, 9:1) gave 153 (684 
mg, 3.2 mmol, 78%) as an orange solid:  mp 66-68 °C;  1H NMR (600 MHz) δ 11.65 (d, J = 11.4 
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Hz, 1 H), 7.15 (dd, J = 12.6 and 7.8 Hz, 1 H), 6.98 (d, J = 8.4 Hz, 1 H), 6.91 (s, 1 H), 6.89 (d, J = 
8.4 Hz, 1 H), 5.31 (d, J = 7.2 Hz, 1 H), 2.31 (s, 3 H), 2.16 (s, 3 H);  13C NMR (150 MHz) δ 198.7 
(+), 141.6 (-), 133.4 (+), 129.4 (+), 127.6 (+), 126.2 (-), 119.1 (-), 113.4 (-), 97.8 (-), 29.4 (-), 
20.7 (-);  IR (neat) 2115, 1641, 1601, 1559, 1471, 1280 cm-1. 
 
2-Acetyl-1,4-dihydro-7-methylquinoxaline (154). 
 Compound 153 (200 mg, 0.9 mmol), Pd(dba)2 (32 mg, 0.06 mmol), dppp (46 mg, 0.1 
mmol) and DMF (5 mL) were combined and reacted at ambient temperature for 3 days.  The 
reaction mixture was then concentrated under high vacuum.  Purification by flash 
chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1 and 3:7) gave 154 (31 mg, 0.16 mmol, 18%) 
as an off-white solid:  1H NMR δ 8.34 (s, 1 H), 7.10 (d, J = 7.9 Hz, 1 H), 7.02 (s, 1 H), 6.83 (d, J 
= 8.2 Hz, 1 H), 4.38 (br s, 2 H), 2.76 (s, 3 H), 2.30 (s, 3 H);  13C NMR (150 MHz) δ 192.6 (+), 
147.7 (+), 138.2 (+), 131.5 (-), 128.3 (+), 125.9 (-), 124.6 (-), 122.3 (+), 118.0 (-), 27.2 (-), 20.1 
(-);  IR (neat) 1687, 1632, 1519, 1242, 1030 cm-1. 
 
2-Isopropylbenzimidazole69 (158). 
 To a solution of 2-nitrosoaminobenzene38 (157) (100 mg, 0.8 mmol) dissolved in DMF (5 
mL) in a threaded pressure tube fitted with a Teflon cap was added 2-methylpropanal (55) (0.15 
mL, 1.7 mmol).  The reaction stirred at 80 °C for 72 h and the solvent was removed under high 
vacuum.  Purification by flash chromatography (hexanes/EtOAc, 9:1, 8:2, 1:1, 3:7 and EtOAc) 
gave 158 (21 mg, 0.131 mmol, 16%). 
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4-Chloro-2-phthalamidonitrobenzene80 (180). 
 The method of Hall et al54 was employed to transform 5-chloro-2-nitroaminobenzene 
(65) (17.50 g, 101.6 mmol) and phthalic anhydride (179) (15.10 g, 101.8 mmol) into 180 (10.00 
g, 33.1 mmol, 33%) as a yellow solid:  1H NMR δ 8.17 (d, J = 8.6 Hz, 1 H), 8.02-7.95 (m, 2 H), 
7.88-7.81 (m, 2 H), 7.60 (dd, J = 8.9 and 2.5 Hz, 1 H), 7.55 (d, J = 2.2 Hz, 1 H);  13C NMR (150 
MHz) δ 165.9 (+), 143.9, 140.2 (+), 134.9 (-), 131.6 (+), 130.9 (-), 129.7 (-), 126.9 (-), 126.8 (+), 
124.3 (-). 
 
5-Chloro-2-phthalamidonitrobenzene80 (181). 
 The same procedure as described for 180 was repeated except that a mixture of 4-chloro-
2-nitroaminobenzene (63) (17.50 g, 101.4 mmol) and phthalic anhydride (179) (14.90 g, 100.6 
mmol) gave 181 (9.27 g, 30.6 mmol, 30%) as a yellow solid:  1H NMR δ 8.19 (d, J = 2.5 Hz, 1 
H), 8.02-7.94 (m, 2 H), 7.88-7.81 (m, 2 H), 7.76 (dd, J = 8.4 and 2.5 Hz, 1 H), 7.50 (d, J = 8.6 
Hz, 1 H);  13C NMR (150 MHz) δ 166.0, 145.8, 135.5, 134.9, 134.1, 131.8, 131.7, 126.0, 124.3, 
124.1. 
 
4-Chloro-2-phthalamidoaminobenzene80 (182). 
 The reduction of 180 was performed according to the method of Hall et al.54  The mixture 
of 180 (7.60 g, 25.1 mmol), iron powder (18.00 g, 322.5 mmol), acetone (200 mL) and acetic 
acid/ H2O (1:1, 40 mL) reacting at reflux with stirring for 2.5 h gave 182 (6.28 g, 23.0 mmol, 
92%) as a yellow solid:  1H NMR δ 7.98-7.95 (m, 2 H), 7.83-7.79 (m, 2 H), 7.22 (dd, J = 8.6 and 
2.2 Hz, 1 H), 7.14 (d, J = 2.5 Hz, 1 H), 6.83 (d, J = 8.4 Hz, 1 H), 3.76 (br s, 2 H);  13C NMR (150 
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MHz) δ 166.9, 142.1, 134.6, 131.8, 130.1, 129.0, 124.0, 123.5, 118.7 (Note: one carbon is not 
seen, possibly due to two overlapping signals). 
 
5-Chloro-2-phthalamidoaminobenzene80 (183). 
 The same procedure as described for 182 was repeated except that a mixture of 181 (9.00 
g, 29.7 mmol), iron powder (21.00 g, 376 mmol), acetone (250 mL) and acetic acid/ H2O (1:1, 50 
mL) after 15 h gave 183 (6.75 g, 24.8 mmol, 83%) as a yellow solid:  1H NMR (600 MHz) δ 
7.96-7.94 (m, 2 H), 7.81-7.79 (m, 2 H), 7.03 (d, J = 7.8 Hz, 1 H), 6.88 (s, 1 H), 6.86 (d, J = 8.4 
Hz, 1 H), 3.83 (br s, 2 H);  13C NMR (150 MHz) δ 167.1 (+), 144.4 (+), 135.7 (+), 134.6 (-), 
131.9 (+), 130.3 (-), 123.9 (-), 119.3 (-), 117.4 (-), 116.4 (+). 
 
4-Chloro-2-phthalamidophenylazide80 (184). 
 The same procedure as described for 131 was repeated except that a mixture of 182 (6.25 
g, 22.9 mmol), H2O (150mL), HCl (concentrated, 25 mL), NaNO2 (1.60 g, 23.2 mmol) and NaN3 
(1.50 g, 23.1 mmol) gave 184 (5.10 g, 17.2 mmol, 75%) as an off-white solid:  1H NMR δ 8.00-
7.93 (m, 2 H), 7.85-7.78 (m, 2 H), 7.49 (dd, J = 8.7 and 2.5 Hz, 1 H), 7.32 (d, J = 2.2 Hz, 1 H), 
7.25 (d, J = 8.7 Hz, 1 H). 
 
5-Chloro-2-phthalamidophenylazide80 (185). 
 The same procedure as described for 131 was repeated except that a mixture of 183 (6.75 
g, 24.8 mmol), H2O (100 mL), HCl (concentrated, 25 mL), NaNO2 (1.80 g, 26.1 mmol) and 
NaN3 (1.70 g, 26.3 mmol) gave 185 (4.40 g, 14.6 mmol, 59%) as an off-white solid:  1H NMR δ 
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7.99-7.92 (m, 2 H), 7.84-7.77 (m, 2 H), 7.30 (d, J = 2.0 Hz, 1 H), 7.26-7.23 (m, 2 H);  13C NMR 
(150 MHz) δ 166.6, 139.1, 136.3, 134.5, 131.8, 131.5, 125.6, 123.9, 121.2, 119.6. 
 
2-Azido-5-chloroaminobenzene80 (186). 
 The same procedure as described for 150 was repeated except that a mixture of 184 (5.10 
g, 16.9 mmol), methanol (35 mL), hydrazine hydrate (85% aqueous solution, 1.2 mL) and NaOH 
(0.25 M, 220 mL) gave 186 (1.50 g, 9.1 mmol, 54%) as an off-white solid:  1H NMR δ 6.93 (d, J 
= 8.4 Hz, 1 H), 6.74 (dd, J = 8.4 and 2.2 Hz, 1 H), 6.67 (d, J = 2.2 Hz, 1 H), 3.88 (br s, 2 H);  13C 
NMR (150 MHz) δ 139.1, 130.7, 123.8, 119.2, 118.7, 115.4. 
 
5-Methyl-2-phthalamidonitrobenzene81 (188). 
 To a refluxing solution of phthaloyl chloride (187) (15 mL, 104 mmol) dissolved in 
toluene (100 mL) was added dropwise a solution of 4-methyl-2-nitroaminobenzene (59) (15.00 
g, 98.6 mmol), pyridine (20.0 mL, 247 mmol) and toluene (100 mL).  The reaction was stirred at 
reflux for 20 h.  The solution was filtered while hot through an oven-heated fritted funnel and the 
filtrate was concentrated.  The product was purified by recrystallization from acetic acid to give 
188 (26.60 g, 94.2 mmol, 96%) as a yellow solid:  1H NMR δ 8.02 (d, J = 1.2 Hz, 1 H), 8.00-
7.78 (m, 2 H), 7.85-7.78 (m, 2 H), 7.59 (dd, J = 8.2 and 1.2 Hz, 1 H), 7.40 (d, J = 8.2 Hz, 1 H);  
13C NMR (150 MHz) δ 166.4 (+), 145.2 (+), 140.6 (+), 134.7 (-), 134.6 (-), 131.7 (+), 130.5 (-), 
126.0 (-), 123.9 (-), 122.8 (+), 21.0 (-). 
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3-Methyl-2-phthalamidonitrobenzene82 (189). 
 The same procedure as described for 188 was repeated except that a mixture of phthaloyl 
chloride (187) (1.5 mL, 10.4 mmol), 6-methyl-2-nitroaminobenzene (67) (1.50 g, 9.9 mmol), 
pyridine (2.0 mL, 24.7 mmol) and toluene (100 mL total) was reacted for 40 h.  Recrystallization 
from acetic acid gave 189 (2.45 g, 8.7 mmol, 88%) as a yellow solid. 
 
3-Nitro-2-phthalamidopyridine (190). 
 The same procedure as described for 188 was repeated except that a mixture of phthaloyl 
chloride (187) (4.0 mL, 27.7 mmol), 2-amino-3-nitropyridine (86) (3.00 g, 21.6 mmol), pyridine 
(6.0 mL, 74.2 mmol) and toluene (100 mL total) was reacted for 42 h.  Recrystallization from 
acetic acid gave 190 (5.56 g, 20.7 mmol, 96%) as a yellow solid:  mp 171-173ºC; 1H NMR δ 
8.94 (dd, J = 4.9 and 1.7 Hz, 1 H), 8.56 (dd, J = 8.2 and 1.5 Hz, 1 H), 8.03-7.98 (m, 2 H), 7.90-
7.80 (m, 2 H), 7.65 (dd, J = 8.2 and 4.7 Hz, 1 H);  13C NMR δ 165.5 (+), 153.3 (-), 142.5 (+), 
139.1 (+), 134.9 (-), 134.5 (-), 131.7 (+), 124.6 (-), 124.3 (-);  IR (neat) 1786, 1735, 1592, 1541, 
1355 cm-1. 
 
5-Methyl-2-phthalamidoaminobenzene83 (191). 
 Compound 188 (26.30 g, 93.2 mmol), 10% Pd/C (4.60 g, 4.3 mmol Pd) and ethanol 
(absolute, 225 mL) were combined in a threaded pressure tube fitted with a teflon cap attached to 
a hydrogenation apparatus.  The tube was flushed 3 times with H2.  The reaction was stirred at 
ambient temperature under H2 (4 atm) for 15 h.  After releasing the pressure, the open flask was 
heated gently to dissolve the solid product.  The hot solution was filtered through an oven-heated 
fritted funnel packed with Celite and washed with boiling ethyl acetate.  The filtrate was 
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concentrated and the product was purified by recrystallization from ethanol to give 191 (20.60 g, 
81.7 mmol, 88%) as a yellow solid:  1H NMR δ 7.97-7.91 (m, 2 H), 7.82-7.75 (m, 2 H), 7.00 (d, 
J = 8.6 Hz, 1 H), 6.74-6.71 (m, 2 H), 3.67 (br s, 2 H), 2.32 (s, 3 H);  13C NMR (150 MHZ) δ 
167.4, 143.0, 140.3, 134.3, 132.0, 128.8, 123.7, 120.2, 118.3, 115.3, 21.2. 
 
3-Methyl-2-phthalamidoaminobenzene82 (192). 
 The same procedure as described for 191 was repeated except that a mixture of 189 (2.30 
g, 8.2 mmol), 10% Pd/C (500 mg, 0.47 mmol Pd), ethanol (absolute, 100 mL) and H2 (3 atm) 
after 44 h at 60 °C gave 192 (1.50 g, 6.1 mmol, 75%) as a yellow solid. 
 
3-Amino-2-phthalamidopyridine (193). 
 The same procedure as described for 191 was repeated except that a mixture of 190 (3.50 
g, 12.9 mmol), 10% Pd/C (700 mg, 0.66 mmol Pd), ethanol (absolute, 50 mL) and H2 (4 atm) 
after 25 h at 60 °C gave 193 (1.50 g, 6.4 mmol, 50%) as a yellow solid:  mp 204-206ºC;  1H 
NMR δ 8.10 (t, J = 3.0 Hz, 1 H), 8.00-7.93 (m, 2 H), 7.83-7.77 (m, 2 H), 7.23 (d, J = 3.2 Hz, 2 
H), 3.85 (br s, 2 H);  13C NMR δ 166.9 (+), 140.0 (+), 139.8 (-), 134.5 (-), 132.8 (+), 132.1 (+), 
125.5 (-), 125.3 (-), 124.0 (-);  IR (neat) 3434, 1716, 1469, 1377 cm-1;  HRMS (EI) calc. for 
C13H9N3O2 239.0695, found 239.0703. 
 
5-Methyl-2-phthalamidophenylazide (194). 
 The same procedure as described for 131 was repeated except that a mixture of 191 
(10.00 g, 39.7 mmol), H2O (300 mL), HCl (concentrated, 75 mL), NaNO2 (3.30 g, 47.8 mmol) 
and NaN3 (3.10 g, 47.7 mmol) gave 194 (9.90 g, 35.5 mmol, 90%) as an off-white solid:  mp 
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161-163ºC;  1H NMR δ 7.97-7.92 (m, 2 H), 7.82-7.76 (m, 2 H), 7.17 (d, J = 7.9 Hz, 1 H), 7.12-
7.07 (m, 2 H), 2.44 (s, 3 H);  13C NMR δ 166.9 (+), 141.1 (+), 137.1 (+), 134.1 (-), 131.8 (+), 
130.0 (-), 126.1 (-), 123.6 (-), 119.8 (+), 119.6 (-), 21.2 (-);  IR (neat) 2110, 1734, 1714, 1514, 
1383 cm-1. 
 
3-Methyl-2-phthalamidophenylazide (195). 
 The same procedure as described for 131 was repeated except that a mixture of 192 (1.37 
g, 5.4 mmol), H2O (100 mL), HCl (concentrated, 25 mL), NaNO2 (450 mg, 6.5 mmol) and NaN3 
(425 mg, 6.54 mmol) gave 195 (1.10 g, 4.1 mmol, 75%) as an off-white solid:  mp 142-144ºC;  
1H NMR δ 7.99-7.94 (m, 2 H), 7.83-7.78 (m, 2 H), 7.41 (t, J = 7.4 Hz, 1 H), 7.16-7.13 (m, 2 H), 
2.21 (s, 3 H);  13C NMR δ 166.9 (+), 139.4 (+), 138.2 (+), 134.3 (-), 132.0 (+), 130.4 (-), 126.9   
(-), 123.8 (-), 121.7 (+), 116.6 (-), 17.9 (-);  IR (neat) 2361, 2124, 1742, 1717, 1469, 1374 cm-1;  
HRMS (EI) calc. for C15H10N4O2 278.0804, found 278.0801. 
 
3-Azido-2-phthalamidopyridine (196). 
 The same procedure as described for 131 was repeated except that a mixture of 193 (1.50 
g, 6.1 mmol), H2O (60 mL), HCl (concentrated, 15 mL), NaNO2 (500 mg, 7.3 mmol) and NaN3 
(485 mg, 7.5 mmol) gave 196 (970 mg, 3.7 mmol, 60%) as an off-white solid:  mp 167-169ºC;  
1H NMR δ 8.47 (dd, J = 1.5 and 4.7 Hz, 1 H), 8.00-7.94 (m, 2 H), 7.85-7.78 (m, 2 H), 7.68 (dd, J 
= 8.2 and 1.5 Hz, 1 H), 7.50 (dd, J = 8.2 and 4.7 Hz, 1 H);  13C NMR δ 166.3, 145.6 (-), 137.2, 
135.3, 134.5 (-), 132.0 (+), 127.9 (-), 125.6 (-), 124.0 (-);  IR (neat) 2126, 1723, 1455, 1374 cm-1. 
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2-Azido-6-methylaminobenzene84 (197). 
 The same procedure as described for 152 was repeated except that a mixture of 195 (1.10 
g, 3.9 mmol), THF (50 mL), ethanol (10 mL) and hydrazine hydrate (85% aqueous solution, 1.5 
mL) was reacted at ambient temperature for 48 h.  The product was purified by column 
chromatography (hexanes/EtOAc, 8:2) to give 197 (343 mg, 2.3 mmol, 60%) as an off-white 
solid:  1H NMR δ 6.93 (d, J = 8.7 Hz, 1 H), 6.86 (d, J = 7.6 Hz, 1 H), 6.72 (t, J = 7.7 Hz, 1 H), 
3.76 (br s, 2 H), 2.16 (s, 3 H);  13C NMR (150 MHz) δ 136.3, 126.7, 124.8, 123.4, 118.4, 115.9, 
17.3. 
 
2-Amino-3-azidopyridine (198). 
 The same procedure as described for 152 was repeated except that a mixture of 196 (840 
mg, 3.2 mmol), THF (20 mL), ethanol (5 mL) and hydrazine hydrate (85% aqueous solution, 1.5 
mL) was reacted at ambient temperature for 26 h.  The insoluble solid was removed by filtration 
and the filtrate was condensed.  The resulting solid was added to HCl (10%, 100 mL) and the 
insoluble solid was removed by filtration.  The filtrate was washed with diethyl ether (3 X 50 
mL).  The aqueous layer was made basic with NaOH (3 M) and was then extracted with diethyl 
ether (4 X 50 mL).  The combined organic phase was dried (MgSO4), filtered and concentrated 
to give 198 (412 mg, 3.1 mmol, 96%) as a brown solid:  mp 71-73ºC;  1H NMR δ 7.86 (dd, J = 
4.9 and 1.5 Hz, 1 H), 7.23 (dd, J = 7.7 and 1.5 Hz, 1 H), 6.70 (dd, J = 7.7 and 4.9 Hz, 1 H), 4.74 
(br s, 2 H);  13C NMR δ 150.9 (+), 143.4 (-), 124.5 (-), 120.3 (+), 113.4 (-);  IR (neat) 3453, 
2120, 1629, 1487, 1257 cm-1;  HRMS (EI) calc. for C5H5N5 135.0545, found 135.0542. 
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5-Chloro-2-hexylbenzimidazole (199). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
5-chloroaminobenzene (186) (302 mg, 1.8 mmol), ethanol (absolute, 70 mL total) and heptanal 
(83) (0.290 mL, 2.2 mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 8:2 and 7:3) 
gave 199 (266 mg, 1.1 mmol, 63%) as a brown solid:  mp 120-122 °C;  1H NMR δ 12.01 (br s, 1 
H), 7.53 (d, J = 2.0 Hz, 1 H), 7.45 (d, J = 8.4 Hz, 1 H), 7.19 (dd, J = 8.6 and 2.0 Hz, 1 H), 2.97 
(t, J = 7.6 Hz, 2 H), 1.85 (pentet, J = 7.4 Hz, 2 H), 1.40-1.10 (m, 6 H), 0.79 (t, J = 6.9 Hz, 3 H);  
13C NMR δ 157.3 (+), 139.3 (+), 137.0 (+), 127.7 (+), 122.6 (-), 115.1 (-), 114.4 (-), 31.3 (+), 
29.3 (+), 28.9 (+), 28.4 (+), 22.3 (+), 13.8 (-);  IR (neat) 2921, 2360, 1450, 1024 cm-1;  HRMS 
(EI) calc. for C13H17C1N2 236.1080, found 236.1071. 
 
2-Isopropyl-5-methylbenzimidazole85 (200). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (300 mg, 2.0 mmol), ethanol (absolute, 70 mL total) and 2-
methylpropanal (55) (0.220 mL, 2.4 mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 
8:2, 7:3, 1:1, 3:7 and EtOAc) gave 200 (249 mg, 1.4 mmol, 71%) as a brown solid:  1H NMR δ 
7.44 (d, J = 8.2 Hz, 1 H), 7.35 (s, 1 H), 7.02 (dd, J = 8.2 and 1.2 Hz, 1 H), 3.33 (septet, J = 6.9 
Hz, 1 H), 2.43 (s, 3 H), 1.48 (d, J = 6.9 Hz, 6 H);  13C NMR δ 160.0, 138.5 (broad signal), 137.0 
(broad signal), 131.8, 123.4, 114.5 (broad signal), 114.0 (broad signal), 29.1, 21.7, 21.6. 
 
2-Hexyl-5-methylbenzimidazole86 (201). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (305 mg, 2.1 mmol), ethanol (absolute, 70 mL total) and heptanal 
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(83) (0.330 mL, 2.5 mmol) after 24 h and chromatography (hexanes/EtOAc, 8:2, 7:3, 1:1, 3:7 
and EtOAc) gave 201 (334 mg, 1.5 mmol, 75%) as a brown solid:  1H NMR δ 12.03 (br s, 1 H), 
7.47 (d, J = 8.2 Hz, 1 H), 7.38 (s, 1 H), 7.04 (dd, J = 8.2 and 1.2 Hz, 1 H), 2.99 (t, J = 7.7 Hz, 2 
H), 2.45 (s, 3 H), 1.87 (pentet, J = 7.4 Hz, 2 H), 1.38-1.15 (m, 6 H), 0.79 (t, J = 6.7 Hz, 3 H);  
13C NMR δ 155.0, 131.8, 123.5, 114.5 (broad signal), 31.4, 29.3, 29.0, 28.3, 22.5, 21.6, 14.0 
(Note: three carbons were not observed due to the slow exchange of the N-H proton, which 
causes these signals to be broadened). 
 
2-Benzyl-5-methylbenzimidazole87 (202) and 5-methylbenzimidazole69 (203). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (300 mg, 2.0 mmol), ethanol (absolute, 70 mL total) and 
phenylacetaldehyde (81) (0.280 mL, 2.4 mmol) after 24 h and chromatography (hexanes/EtOAc, 
8:2, 7:3, 1:1, 3:7 and EtOAc) gave 202 (47 mg, 0.21 mmol, 10%) as a brown solid and 203 (107 
mg, 0.81 mmol, 40%) as an off-white solid. 
 Alternate procedure for 202 and 203.  2-azido-4-methylaminobenzene (152) (300 mg, 
2.0 mmol), ethanol (absolute, 70 mL total) and phenylacetaldehyde (81) (0.300 mL, 2.6 mmol) 
were reacted as described for 151 with the following change:  Glacial acetic acid (25 µL) was 
added to the azide solution before heating to reflux.  After 24 h and chromatography 
(hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1, 3:7 and EtOAc), 202 (87 mg, 0.39 mmol, 19%) was isolated 
as a brown solid and 203 (79 mg, 0.60 mmol, 30%) as an off-white solid. 
 Alternate procedure for 203.  The same procedure as described for 151 was repeated 
except that a mixture of 2-azido-4-methylaminobenzene (152) (306 mg, 2.1 mmol), ethanol 
(absolute, 70 mL total) and paraformaldehyde (78 mg, 2.6 mmol) after 24 h and chromatography 
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(hexanes/EtOAc, 6:4, 1:1, 3:7 and EtOAc) gave 203 (49 mg, 0.37 mmol, 18%) as an off-white 
solid. 
 
5-Methyl-2-tert-butylbenzimidazole88 (206). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (300 mg, 2.0 mmol), ethanol (absolute, 70 mL total) and 
trimethylacetaldeyde (205) (0.270 mL, 2.5 mmol) after 24 h and chromatography 
(hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1, 3:7 and EtOAc) gave 206 (94 mg, 0.5 mmol, 25%) as a 
brown solid. 
 
2,5-Dimethylbenzimidazole69 (208). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (302 mg, 2.0 mmol), ethanol (absolute, 70 mL total) and 
acetaldehyde (207) (0.140 mL, 2.5 mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 
8:2, 7:3, 1:1, 3:7 and EtOAc) gave 208 (99 mg, 0.7 mmol, 33%) as a brown solid. 
 
(E)-5-Methyl-2-(1-propenyl)benzimidazole89 (210). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
4-methylaminobenzene (152) (308 mg, 2.1 mmol), ethanol (absolute, 70 mL total) and 
crotonaldeyde (209) (0.20 mL, 2.4 mmol) after 24 h and chromatography (hexanes/EtOAc, 95:5, 
9:1, 8:2, 7:3, 1:1, 3:7 and EtOAc) gave 210 (50 mg, 0.29 mmol, 14%). 
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2-Isopropy1-4-methylbenzimidazole70 (136) and 4-methylbenzimidazole90 (211). 
 The same procedure as described for 151 was repeated except that a mixture of 2-azido-
6-methylaminobenzene (197) (280 mg, 1.9 mmol), ethanol (absolute, 70 mL total) and 2-
methylpropanal (55) (0.210 mL, 2.3 mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 
8:2, 7:3, 1:1, 3:7 and EtOAc) gave 136 (226 mg, 1.3 mmol, 69%) as a brown solid and 211 (21 
mg, 0.16 mmol, 8%) as an off-white solid:  211 1H NMR δ 8.60 (br s, 1 H), 8.12 (s, 1 H), 7.49 
(d, J = 7.9 Hz, 1 H), 7.20 (t, J = 7.4 Hz, 1 H), 7.93 (d, J = 7.4 Hz, 1 H), 2.62 (s, 3 H). 
 Alternate procedure for 136.  See page 90. 
 
2-Isopropylimidazo[b]pyridine91 (212) and 2,3-diaminopyridine69 (213). 
 The same procedure as described for 151 was repeated except that a mixture of 2-amino-
3-azidopyridine (198) (302 mg, 2.2 mmol), ethanol (absolute, 70 mL total) and 2-methylpropanal 
(55) (0.250 mL, 2.8 mmol) after 24 h and chromatography (hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1, 
3:7 and EtOAc) gave 212 (27 mg, 0.17 mmol, 7%) and 213 (81 mg, 0.74 mmol, 33%) as brown 
solids:  212 mp 140-142 °C;  1H NMR δ 8.36 (dd, J = 4.9 and 1.5 Hz, 1 H), 8.07 (d, J = 7.9 Hz, 1 
H), 7.25 (dd, J = 7.9 and 4.9 Hz, 1 H), 3.40 (septet, J = 7.2 Hz, 1 H), 1.58 (d, J = 7.2 Hz, 6 H);  
13C NMR δ 162.4 (+), 149.2 (+), 141.6 (-), 136.0 (+), 127.1 (-), 117.7 (-), 29.7 (-), 21.3 (-);  IR 
(neat) 2971, 2750, 1609, 1410, 1271 cm-1. 
 
2-Cyclopropylmethyl-5-methylbenzimidazole (217). 
 A mixture of 2-cyclopropylethanol (216) (300 mg, 3.5 mmol) and PCC (980 mg, 4.6 
mmol) dissolved in CH2Cl2 (anhydrous, 50 mL) stirred at ambient temperature for 7 h.  The 
solution was then filtered through a fritted funnel packed with a thin layer of silica gel.  To the 
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filtrate (crude aldehyde) in a threaded pressure vessel fitted with a teflon cap was added 2-azido-
4-methylaminobenzene (152) (310 mg, 2.1 mmol).  The reaction was stirred at 100 °C for 24 h 
and the mixture was then concentrated.  Purification by column chromatography 
(hexanes/EtOAc, 9:1, 8:2, 7:3, 1:1 and 3:7) gave 217 (73 mg, 0.39 mmol, 11%):  mp 155-157ºC;  
1H NMR δ 7.45 (d, J = 8.2 Hz, 1 H), 7.34 (s, 1 H), 7.03 (d, J = 8.2 Hz, 1 H), 2.87 (d, J = 7.2 Hz, 
2 H), 2.44 (s, 3 H), 1.29-1.13 (m, 1 H), 0.58-0.50 (m, 2 H), 0.28-0.22 (m, 2 H);  13C NMR δ 
154.8 (+), 138.5 (+), 137.0 (+), 131.6 (+), 123.3 (-), 114.4 (-), 114.1 (-), 34.0 (+), 21.5 (-), 9.5 (-), 
4.8 (+);  IR (neat) 3005, 2919, 2865, 1449, 1282 cm-1;  HRMS (EI) calc. for C12H14N2 (M-H+) 
185.1079, found 185.1078. 
 
6-Chloro-1,3-dimethyluracil69 (218). 
 To a solution of 1,3-dimethylbarbituric acid (224) (6.50 g, 41.6 mmol) and H2O (2 mL) 
was added dropwise phosphorus oxychloride (50.0 ml, 536 mmol) (Note: a violent reaction 
occurred during the addition of the first few mL).  The reaction was stirred at reflux for 75 
minutes and then the phosphorus oxychloride was removed by distillation.  To the resulting 
material was added H2O (300 mL).  This solution was extracted with CHCl3 (4 X 75 mL).  The 
combined organic phases were dried (MgSO4), filtered and concentrated.  The product was 
purified by recrystallization from H2O to give 218 (5.64 g, 32.3 mmol, 78%) as a pale yellow 
solid. 
 
6-Bromo-1,3-dimethyluracil92 (219). 
 A solution of 1,3-dimethylbarbituric acid (224) (1.00 g, 6.4 mmol) and phosphorus 
tribromide (5.0 ml, 53.0 mmol) was heated at reflux for 75 minutes.  The solution was poured 
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onto ice (100 mL) and extracted with EtOAc (5 X 30 mL).  The combined organic phases were 
dried (MgSO4), filtered and concentrated.  Purification by flash chromatography 
(hexanes/EtOAc, 8:2, 6:4 and 1:1) gave 219 (458 mg, 2.1 mmol, 33%) as a brown solid:  1H 
NMR δ 6.16 (s, 1 H), 3.63 (s, 3 H), 3.33 (s, 3 H);  13C NMR (150 MHz) δ 160.7 (+), 150.7 (+), 
136.5 (+), 105.9 (-), 36.5 (-), 28.2 (-). 
 
6-Iodo-1,3-dimethyluracil93 (220). 
 To a solution of NaI (3.04 g, 20.3 mmol) dissolved in acetone (10 mL) in a threaded 
pressure vessel was added 6-chloro-1,3-dimethyluracil (218) (500 mg, 2.9 mmol).  The reaction 
vessel was then sealed with a Teflon cap and heated to 130 °C for 81 h.  The mixture was 
concentrated and H2O (75 mL) was added.  This solution was extracted with EtOAc (4 X 30 
mL).  The combined organic phases were dried (MgSO4), filtered and concentrated.  The product 
was purified by recrystallization from EtOAc to give 220 (490 mg, 1.8 mmol, 64%) as a brown 
solid. 
 
2,2'-Dinitrobiphenyl69 (227) and 6-(2-nitrophenyl)-1,3-dimethyluracil (226). 
 To a solution of 6-iodo-1,3-dimethyluracil (220) (267 mg, 1.0 mmol) and 2-(tri-n-
butylstannyl)-1-nitrobenzene60 (225) (494 mg, 1.2 mmol) dissolved in N-methylpyrrolidinone (3 
mL) under argon atmosphere was added PdCl2(PhCN)2 (23 mg, 0.06 mmol), triphenylarsine (34 
mg, 0.11 mmol) and CuI (21 mg, 0.11 mmol).  The reaction was stirred at reflux for 20 h.  The 
solution was diluted with EtOAc (50 mL) and washed with NH4OH (10%, 3 X 20 mL) and H2O 
(2 X 20 mL).  The combined aqueous layers were extracted with EtOAc (2 X 25 mL).  The 
combined organic phases were dried (MgSO4), filtered and concentrated.  Purification by flash 
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chromatography (hexanes/EtOAc, 9:1, 8:2, 6:4, 1:1, 3:7 and EtOAc) gave 227 (53 mg, 0.22 
mmol, 36%) as a brown solid and 226 (126 mg, 0.48 mmol, 48%) as a tan solid:  226 1H NMR δ 
8.28 (dd, J = 7.9 and 1.2 Hz, 1 H), 7.86-7.72 (m, 2 H), 7.44 (dd, J = 7.2 and 1.7 Hz, 1 H), 5.60 (s, 
1 H), 3.43 (s, 3 H), 3.13 (s, 3 H);  13C NMR δ 162.1, 151.3, 146.6, 134.5, 131.5, 130.6, 128.4, 
125.3, 101.4, 33.6, 28.1 (Note: one carbon signal is missing). 
 
1,3-Dimethyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)dione (228). 
 The same procedure as described for 57 was repeated except that a mixture of 6-(2-
nitrophenyl)-1,3-dimethyluracil (226) (120 mg, 0.5 mmol), Pd(dba)2 (16 mg, 0.03 mmol), dppp 
(11 mg, 0.03 mmol), phen (10 mg, 0.06 mmol) and DMF (5 mL) was reacted at 70 °C under CO 
(6 atm) for 24 h.  The reaction mixture was then concentrated.  Purification by flash 
chromatography (hexanes/EtOAc, 9:1, 7:3, 1:1, 3:7 and EtOAc) gave 228 (9 mg, 0.04 mmol, 
9%) as a tan solid:  1H NMR (600 MHz, DMSO-d6) δ 12.00 (s, 1 H), 8.08 (d, J = 7.8 Hz, 1 H), 
7.47 (d, J = 8.4 Hz, 1 H), 7.40 (dt, J = 6.6 and 0.6 Hz, 1 H), 7.15 (dt, J = 7.5 and 0.6 Hz, 1 H), 
3.84 (s, 3 H), 3.33 (s, 3 H);  13C NMR (150 MHz, DMSO-d6) δ 155.9, 151.0, 138.1, 126.8, 126.6, 
121.7, 119.8, 115.3, 113.9, 113.0, 32.5, 28.0. 
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